Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer, January 2015

Free Subscription


Retrieve all available abstracts of the following 994 articles:
HTML format


Single Articles

  1. YANG Y, Xu H, Shen J, Yang Y, et al
    RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.
    Cell Death Dis. 2015;6:e1760.
    Abstract     Related articles   

  2. ZHANG S, Yu YH, Zhang Y, Qu W, et al
    Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.
    Am J Cancer Res. 2015;5:854-68.
    Abstract     Related articles   

  3. ZHAO XL, Zhao ZH, Xu WC, Hou JQ, et al
    Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Int J Clin Exp Pathol. 2015;8:1954-60.
    Abstract     Related articles   

  4. DANCKERS M, Zhou F, Nimeh D, Belmont HM, et al
    Pulmonary metastasis in a patient with simultaneous bladder cancer and relapsing granulomatosis with polyangiitis.
    Am J Case Rep. 2015;16:287-91.
    Abstract     Related articles   

  5. SU CC, Liu SH, Lee KI, Huang KT, et al
    Cantharidin Induces Apoptosis Through the Calcium/PKC-Regulated Endoplasmic Reticulum Stress Pathway in Human Bladder Cancer Cells.
    Am J Chin Med. 2015;43:581-600.
    Abstract     Related articles   

  6. CHENG Y, Yang X, Deng X, Zhang X, et al
    MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Tumour Biol. 2015.
    Abstract     Related articles   

  7. KUANG LI, Song WJ, Qing HM, Yan S, et al
    CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis.
    Genet Mol Res. 2015;14:3921-31.
    Abstract     Related articles   

  8. SUN E, Nian X, Liu C, Fan X, et al
    Construction of recombinant human IFNalpha-2b BCG and its antitumor effects on bladder cancer cells in vitro.
    Genet Mol Res. 2015;14:3436-49.
    Abstract     Related articles   

  9. PENG Y, Dong W, Lin TX, Zhong GZ, et al
    MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
    Oncotarget. 2015.
    Abstract     Related articles   

  10. UGURLU O, Baltaci S, Aslan G, Can C, et al
    Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?
    Korean J Urol. 2015;56:357-64.
    Abstract     Related articles   

  11. WANG T, Liu Y, Yuan W, Zhang L, et al
    Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury.
    Mol Med Rep. 2015 May 12. doi: 10.3892/mmr.2015.3769.
    Abstract     Related articles   

  12. CANYILMAZ E, Yoney A, Serdar L, Uslu GH, et al
    Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer.
    J Geriatr Oncol. 2015 May 7. pii: S1879-4068(15)00033.
    Abstract     Related articles   

  13. FEUERSTEIN MA, Jacobs M, Piciocchi A, Bochner B, et al
    Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review.
    Urol Oncol. 2015 May 5. pii: S1078-1439(15)00152.
    Abstract     Related articles   

  14. VETORAZZO FILHO JE, Bahia LA, Vedovato BC, Maron PE, et al
    Cystectomy with orthotopic ileal neobladder reconstruction for treatment of bladder contracture after intravesical bacillus Calmette-Guerin therapy.
    Einstein (Sao Paulo). 2014;12:502-4.
    Abstract     Related articles   

  15. ADRAKTAS D, Caserta M, Tchelepi H
    Paraganglioma of the urinary bladder.
    Ultrasound Q. 2014;30:233-5.
    Abstract     Related articles   

  16. YAN Y, Yang FQ, Zhang HM, Li J, et al
    Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Int J Clin Exp Pathol. 2014;7:4231-8.
    Abstract     Related articles   

  17. KANG YJ, Park DJ, Kim S, Kim SW, et al
    Vesicoenteric fistula due to bladder squamous cell carcinoma.
    Korean J Urol. 2014;55:496-8.
    Abstract     Related articles   

  18. CHO YH, Seo YH, Chung SJ, Hwang I, et al
    Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.
    Korean J Urol. 2014;55:453-9.
    Abstract     Related articles   

  19. ZHENG X, Zhuge J, Bezerra SM, Faraj SF, et al
    High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
    J Hematol Oncol. 2014;7:47.
    Abstract     Related articles   

  20. PATHURI G, Madka V, Hedrick AF, Lightfoot SA, et al
    Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.
    Mol Pharm. 2014;11:2948-53.
    Abstract     Related articles   

  21. ZHANG Q, Zhao Z, Ma Y, Wang H, et al
    Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Urol Oncol. 2014;32:798-805.
    Abstract     Related articles   

  22. LOURENCO LM, Pereira PM, Maciel E, Valega M, et al
    Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy.
    Chem Commun (Camb). 2014;50:8363-6.
    Abstract     Related articles   

  23. EHDAIE B, Atoria CL, Lowrance WT, Herr HW, et al
    Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
    Urol Oncol. 2014;32:779-84.
    Abstract     Related articles   

  24. VAA B, Kohli M, Price KA, Swetz KM, et al
    Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  25. AGILLI M, Aydin I, Aydin FN, Kurt YG, et al
    Neutrophil-lymphocyte ratio evaluation in patients undergoing radical cystectomy.
    Urol Oncol. 2014;32:939.
    Abstract     Related articles   

  26. MONN MF, Cary KC, Kaimakliotis HZ, Flack CK, et al
    National trends in the utilization of robotic-assisted radical cystectomy: an analysis using the Nationwide Inpatient Sample.
    Urol Oncol. 2014;32:785-90.
    Abstract     Related articles   

  27. BEATTIE W, Qin X, Wang L, Ma H, et al
    Clog-free cell filtration using resettable cell traps.
    Lab Chip. 2014;14:2657-65.
    Abstract     Related articles   

    Simple benchmark for complex dose finding studies.
    Biometrics. 2014;70:389-97.
    Abstract     Related articles   

  29. AL BASHIR S, Yilmaz A, Gotto G, Trpkov K, et al
    Long term outcome of primary urothelial papilloma: a single institution cohort.
    Pathology. 2014;46:37-40.
    Abstract     Related articles   

  30. WANG HJ , Pui MH, Guo Y, Yang D, et al
    Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection.
    Abdom Imaging. 2013.
    Abstract     Related articles   

  31. PAKASH J, Goel A, Garg M
    Re: Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
    J Endourol. 2014;28:1246.
    Abstract     Related articles   

  32. APOLO AB, Vogelzang NJ, Theodorescu D
    New and promising strategies in the management of bladder cancer.
    Am Soc Clin Oncol Educ Book. 2015;35:105-12.
    Abstract     Related articles   

  33. LI Y, Deng H, Lv L, Zhang C, et al
    The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
    Oncotarget. 2015;6:10195-206.
    Abstract     Related articles   

  34. TANG K, Zhou H, Xiao H, Zeng J, et al
    A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    J Exp Clin Cancer Res. 2015;34:53.
    Abstract     Related articles   

  35. XU Z, Yu YQ, Ge YZ, Zhu JG, et al
    MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
    Tumour Biol. 2015.
    Abstract     Related articles   

  36. LI Q, Li JZ, Xu WH, Gao L, et al
    Pemetrexed in treating patients with metastatic bladder cancer.
    Asian Pac J Cancer Prev. 2015;16:3839-41.
    Abstract     Related articles   

  37. GAN C, Mostafid H, Khan MS, Lewis DJ, et al
    Corrigendum: BCG immunotherapy for bladder cancer-the effects of substrain differences.
    Nat Rev Urol. 2015 May 19. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  38. BRUNETTI J, Falciani C, Lelli B, Minervini A, et al
    Neurotensin branched Peptide as a tumor-targeting agent for human bladder cancer.
    Biomed Res Int. 2015;2015:173507.
    Abstract     Related articles   

  39. SANTACATERINA A, Platania A, Palazzolo C, Spatola C, et al
    Very elderly (>80 years), frail patients with muscle-invasive bladder cancer and comorbidities: is curative irradiation feasible?
    Tumori. 2015;0:0.
    Abstract     Related articles   

  40. HUANG L, Peng Y, Zhong G, Xie W, et al
    PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.
    Oncotarget. 2015.
    Abstract     Related articles   

  41. DIRIX P, Vingerhoedt S, Joniau S, Van Cleynenbreugel B, et al
    Hypofractionated palliative radiotherapy for bladder cancer.
    Support Care Cancer. 2015.
    Abstract     Related articles   

  42. WANG J, Zhang X, Wang L, Dong Z, et al
    Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
    J Surg Oncol. 2015 May 14. doi: 10.1002/jso.23937.
    Abstract     Related articles   

  43. EL-GAMAL EM, Gouida MS
    Flow cytometric study of cell cycle and DNA ploidy in belharzial bladder cancer.
    Clin Lab. 2015;61.
    Abstract     Related articles   

  44. SUN WX, Chen YH, Liu ZZ, Xie JJ, et al
    Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
    Mol Genet Genomics. 2015;290:709-25.
    Abstract     Related articles   

  45. GRAVAS S, Stenzl A
    The Storz professional image enhancement system(spies) nonmuscle-invasive bladder cancer study:a multicenter international randomized controlled study.
    J Endourol. 2014;28:1254-5.
    Abstract     Related articles   

  46. KONG V, Rosewall T, Chen S, Craig T, et al
    Deriving patient-specific planning target volume for partial bladder image guided radiation therapy.
    Pract Radiat Oncol. 2014;4:323-9.
    Abstract     Related articles   

  47. TOBIS S, Heinlen JE, Ruel N, Lau C, et al
    Effect of alvimopan on return of bowel function after robot-assisted radical cystectomy.
    J Laparoendosc Adv Surg Tech A. 2014;24:693-7.
    Abstract     Related articles   

  48. JALIL R, Jahan KA, Brodie A, Kalsi J, et al
    The bladder or not the bladder that is the question!
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  49. BOLT HM
    Causation of human urothelial cancer: there are challenging new data!
    Arch Toxicol. 2014;88:1769-70.
    Abstract     Related articles   

  50. KNEZ VM, Barrow W, Lucia MS, Wilson S, et al
    Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    J Med Case Rep. 2014;8:275.
    Abstract     Related articles   

  51. STOWERS KH, Hartman AD, Gustin J
    Diltiazem for the management of malignancy-associated perineal pain and tenesmus.
    J Palliat Med. 2014;17:1075-7.
    Abstract     Related articles   

  52. HABERMAN K, Wittig K, Yuh B, Ruel N, et al
    The effect of nerve-sparing robot-assisted radical cystoprostatectomy on erectile function in a preoperatively potent population.
    J Endourol. 2014;28:1352-6.
    Abstract     Related articles   

  53. CHAABANE A, M'Sakni I, Yahia M, Bougrine F, et al
    [Prognostic value of markers of aggressiveness of urinary bladder tumours evaluated by immunohistochemistry].
    Tunis Med. 2014;92:208-13.
    Abstract     Related articles   

  54. DESAI MM, de Abreu AL, Goh AC, Fairey A, et al
    Robotic intracorporeal urinary diversion: technical details to improve time efficiency.
    J Endourol. 2014;28:1320-7.
    Abstract     Related articles   

  55. ROY C, Deb AR, Pal M, Das D, et al
    Small cell carcinoma of the urinary bladder: a case report and review of the literature.
    J Indian Med Assoc. 2014;112:57-9.
    Abstract     Related articles   

  56. TREGLIA G, Ceriani L, Merlo E, Ruberto T, et al
    Added value of fused somatostatin receptor imaging/magnetic resonance imaging in a rare case of paraganglioma of the urinary bladder.
    Rev Esp Med Nucl Imagen Mol. 2014;33:122-4.
    Abstract     Related articles   

  57. EL GENDY H, Madkour B, Abdelaty S, Essawy F, et al
    Galectin 3 for the diagnosis of bladder cancer.
    Arab J Urol. 2014;12:178-81.
    Abstract     Related articles   

  58. OZYALVACLI G, Ozyalvacli ME, Astarci HM, Boran C, et al
    Evaluation of different p16 immunostaining methods and the prognostic role of p16/Ki-67 combined expression in non-muscle invasive bladder cancers.
    Pol J Pathol. 2015;66:57-66.
    Abstract     Related articles   

  59. POON SL, Huang MN, Choo Y, McPherson JR, et al
    Mutation signatures implicate aristolochic acid in bladder cancer development.
    Genome Med. 2015;7:38.
    Abstract     Related articles   

  60. DU M, Shi D, Yuan L, Li P, et al
    Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
    Sci Rep. 2015;5:10437.
    Abstract     Related articles   

  61. MOSCHINI M, Dell' Oglio P, Capogrosso P, Cucchiara V, et al
    Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.
    Clin Genitourin Cancer. 2015 May 4. pii: S1558-7673(15)00093.
    Abstract     Related articles   

  62. HELENIUS M, Dahlman P, Lonnemark M, Brekkan E, et al
    Comparison of post contrast CT urography phases in bladder cancer detection.
    Eur Radiol. 2015.
    Abstract     Related articles   

  63. FUGE O, Vasdev N, Allchorne P, Green JS, et al
    Immunotherapy for bladder cancer.
    Res Rep Urol. 2015;7:65-79.
    Abstract     Related articles   

  64. AOUN F, El Rassy E, Kourie HR, Hawaux E, et al
    Vulvar metastasis from bladder cancer.
    Case Rep Obstet Gynecol. 2015;2015:324634.
    Abstract     Related articles   

  65. TAUBERT H, Wach S, Jung R, Pugia M, et al
    Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients.
    Mol Med. 2015 May 13. doi: 10.2119/molmed.2014.00250.
    Abstract     Related articles   

  66. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
    BMC Genomics. 2015;16:403.
    Abstract     Related articles   

  67. KUZAKA B, Janiak M, Wlodarski KH, Radziszewski P, et al
    Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence.
    Arch Med Sci. 2015;11:378-84.
    Abstract     Related articles   

    The history, genotoxicity, and carcinogenicity of carbon-based fuels and their emissions. Part 3: diesel and gasoline.
    Mutat Res Rev Mutat Res. 2015;763:30-85.
    Abstract     Related articles   

  69. ERRICO A
    Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer.
    Nat Rev Clin Oncol. 2015;12:63.
    Abstract     Related articles   

  70. SEE WA
    Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenb
    Urol Oncol. 2014;32:1350.
    Abstract     Related articles   

  71. SEE WA
    Commentary on "Robot-assisted laparoscopic vs open radical cystectomy: Comparison of complications and perioperative oncological outcomes in 200 patients." Kader AK, Richards KA, Krane LS, Pettus JA, Smith JJ, Hemal AK, Division of Urology, UC San Die
    Urol Oncol. 2014;32:1348.
    Abstract     Related articles   

  72. KIM IK, Lee JY, Kwon JK, Park JJ, et al
    Prognostic factors for urachal cancer: a bayesian model-averaging approach.
    Korean J Urol. 2014;55:574-80.
    Abstract     Related articles   

  73. TARPLIN S, Osterberg EC, Robinson BD, Herman MP, et al
    Perivascular epithelioid cell tumour of the bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  74. ZHANG Y, Huang J, Feng H, Tang Y, et al
    Primary multiple clear cell variant urothelial carcinomas of urinary bladder: a rare case report.
    Int J Clin Exp Pathol. 2014;7:3385-8.
    Abstract     Related articles   

  75. CONTI SL, Honeycutt J, Odegaard JI, Gonzalgo ML, et al
    Alterations in DNA Methylation May Be the Key to Early Detection and Treatment of Schistosomal Bladder Cancer.
    PLoS Negl Trop Dis. 2015;9:e0003696.
    Abstract     Related articles   

  76. JAGER W, Xue H, Hayashi T, Janssen C, et al
    Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Oncotarget. 2015.
    Abstract     Related articles   

  77. RAGER JE, Tilley SK, Tulenko SE, Smeester L, et al
    Identification of Novel Gene Targets and Putative Regulators of Arsenic-Associated DNA Methylation in Human Urothelial Cells and Bladder Cancer.
    Chem Res Toxicol. 2015.
    Abstract     Related articles   

  78. XU C, Zeng S, Zhang Z, Song R, et al
    Deceptive muscle invasive bladder cancer recurrence with benign biopsy foci after bladder sparing treatment.
    Medicine (Baltimore). 2015;94:e898.
    Abstract     Related articles   

  79. INAMOTO T, Taniguchi K, Takahara K, Iwatsuki A, et al
    Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.
    Oncotarget. 2015.
    Abstract     Related articles   

  80. GOOSSENS ME, Zeegers MP, Bazelier MT, De Bruin ML, et al
    Risk of bladder cancer in patients with diabetes: a retrospective cohort study.
    BMJ Open. 2015;5:e007470.
    Abstract     Related articles   

  81. FRANTZI M, Latosinska A, Fluhe L, Hupe MC, et al
    Developing proteomic biomarkers for bladder cancer: towards clinical application.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  82. LEW CR, Guin S, Theodorescu D
    Targeting glycogen metabolism in bladder cancer.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  83. Bladder cancer: Dorsolateral peritoneal layer adaptation following PLND.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  84. CHENG C, Varn FS, Marsit CJ
    E2F4 Program is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.
    Mol Cancer Res. 2015 Jun 1. pii: molcanres.0120.2015.
    Abstract     Related articles   

  85. ZHANG GM, Zhu Y, Luo L, Wan FN, et al
    Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  86. POLETAJEW S, Braticevici B, Brisuda A, Cauni V, et al
    Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients.
    Cent European J Urol. 2015;68:9-14.
    Abstract     Related articles   

  87. EKIN RG, Akarken I, Zorlu F, Tarhan H, et al
    Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  88. NIWA N, Matsumoto K, Hayakawa N, Ito Y, et al
    Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis.
    Urol Oncol. 2015 May 28. pii: S1078-1439(15)00197.
    Abstract     Related articles   

  89. FANTONY JJ, Abern MR, Gopalakrishna A, Owusu R, et al
    Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Urol Oncol. 2015 May 28. pii: S1078-1439(15)00193.
    Abstract     Related articles   

  90. CHEN Q, Chong T, Yin J, Luo P, et al
    Molecular events are associated with resistance to vinblastine in bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2015;61:33-8.
    Abstract     Related articles   

  91. LAMMERS RJ, Hendriks JC, Rodriguez Faba OR, Witjes WP, et al
    Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
    World J Urol. 2015.
    Abstract     Related articles   

  92. MASSARI F, Santoni M, Ciccarese C, Brunelli M, et al
    Emerging concepts on drug resistance in bladder cancer: Implications for future strategies.
    Crit Rev Oncol Hematol. 2015 May 15. pii: S1040-8428(15)00094.
    Abstract     Related articles   

  93. LI HH, Rodriguez VL, Green OL, Hu Y, et al
    Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
    Int J Radiat Oncol Biol Phys. 2015;91:65-72.
    Abstract     Related articles   

  94. SOGAARD KK, Farkas DK, Pedersen L, Weiss NS, et al
    Pneumonia and the incidence of cancer: a Danish nationwide cohort study.
    J Intern Med. 2015;277:429-38.
    Abstract     Related articles   

  95. LOU X, Zhuang Y, Zuo X, Jia Y, et al
    Real-time, Quantitative Lighting-up Detection of Telomerase in Urines of Bladder Cancer Patients by AIEgens.
    Anal Chem. 2015.
    Abstract     Related articles   

  96. COGOI S, Zorzet S, Shchekotikhin AE, Xodo LE, et al
    Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells.
    J Med Chem. 2015.
    Abstract     Related articles   

  97. HORN T, Laus J, Seitz AK, Maurer T, et al
    The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  98. BOGGS DH, Guerrero M, Patel K, Chen S, et al
    Pelvic local recurrence in a patient with muscle-invasive bladder cancer treated with interstitial thermal therapy and interstitial brachytherapy.
    Pract Radiat Oncol. 2015 Jun 5. pii: S1879-8500(15)00149.
    Abstract     Related articles   

  99. LIN WC, Chen JH
    Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer.
    Transl Oncol. 2015;8:217-30.
    Abstract     Related articles   

  100. ISKENDER B, Izgi K, Karaca H, Canatan H, et al
    Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.
    J Nat Med. 2015.
    Abstract     Related articles   

  101. SANGUEDOLCE F, Cormio A, Bufo P, Carrieri G, et al
    Molecular markers in bladder cancer: Novel research frontiers.
    Crit Rev Clin Lab Sci. 2015.
    Abstract     Related articles   

  102. PETRIOLI R, Roviello G, Fiaschi AI, Laera L, et al
    Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.
    Anticancer Drugs. 2015.
    Abstract     Related articles   

  103. AINE M, Eriksson P, Liedberg F, Sjodahl G, et al
    Biological determinants of bladder cancer gene expression subtypes.
    Sci Rep. 2015;5:10957.
    Abstract     Related articles   

  104. GAUTAM KA, Pooja S, Sankhwar SN, Sankhwar PL, et al
    c.29C>T polymorphism in the transforming growth factor-beta1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
    Cytokine. 2015 Jun 2. pii: S1043-4666(15)00203.
    Abstract     Related articles   

  105. YE Z, Hu J, Song X, Li F, et al
    A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study.
    Sci Rep. 2015;5:10905.
    Abstract     Related articles   

  106. YEH CR, Hsu I, Song W, Chang H, et al
    Fibroblast ERalpha promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.
    Am J Cancer Res. 2015;5:1146-57.
    Abstract     Related articles   

  107. TRINKLER F, Tuma J
    [Ultrasound diagnosis 63. Tumor of the bladder wall, partially necrotic (calcified)].
    Praxis (Bern 1994). 2015;104:431-3.
    Abstract     Related articles   

  108. JIA Z, Ai X, Sun F, Zang T, et al
    Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.
    Tumori. 2015;101:117-22.
    Abstract     Related articles   

  109. WU CT, Lin WY, Chang YH, Lin PY, et al
    DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  110. HUANG W, Chen Y, Liu Y, Zhang Q, et al
    Roles of ERbeta and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen.
    Biomed Res Int. 2015;2015:251780.
    Abstract     Related articles   

  111. WALKER M, French SD, Feldman-Stewart D, Siemens DR, et al
    A call for theory-informed approaches to knowledge translation studies: an example of chemotherapy for bladder cancer.
    Curr Oncol. 2015;22:178-81.
    Abstract     Related articles   

  112. GUANCIAL EA, Roussel B, Bergsma DP, Bylund KC, et al
    Bladder cancer in the elderly patient: challenges and solutions.
    Clin Interv Aging. 2015;10:939-49.
    Abstract     Related articles   

  113. LIU Q, Zhang C, Ding X, Deng H, et al
    Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.
    Sci Rep. 2015;5:11464.
    Abstract     Related articles   

  114. NOMURA S, Suzuki Y, Takahashi R, Terasaki M, et al
    Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy : DYRK2 is associated with survival in bladder cancer.
    BMC Urol. 2015;15:53.
    Abstract     Related articles   

  115. BOOTH BB, Rasmussen A, Jensen JB
    Evaluating sexual function in women after radical cystectomy as treatment for bladder cancer.
    Scand J Urol. 2015.
    Abstract     Related articles   

  116. CHUANG CH, Wu TF, Chen CH, Chang KC, et al
    Lab on a chip for multiplexed immunoassays to detect bladder cancer using multifunctional dielectrophoretic manipulations.
    Lab Chip. 2015.
    Abstract     Related articles   

  117. YUAN SY, Cheng CL, Ho HC, Wang SS, et al
    Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder Cancer cells and inhibits bladder tumour growth in vivo.
    Eur J Pharmacol. 2015 Jun 15. pii: S0014-2999(15)30068.
    Abstract     Related articles   

  118. CHEN CL, Chung T, Wu CC, Ng KF, et al
    Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
    Mol Cell Proteomics. 2015 Jun 16. pii: mcp.M115.051524.
    Abstract     Related articles   

  119. ZHU H, Yun F, Shi X, Wang D, et al
    Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
    Int J Mol Med. 2015 Jun 17. doi: 10.3892/ijmm.2015.2250.
    Abstract     Related articles   

  120. SHIM JS, Choi H, Noh TI, Tae JH, et al
    The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Korean J Urol. 2015;56:429-34.
    Abstract     Related articles   

  121. MA H, Zhang X, Li X, Li R, et al
    Electrochemical immunosensor for detecting typical bladder cancer biomarker based on reduced graphene oxide-tetraethylene pentamine and trimetallic AuPdPt nanoparticles.
    Talanta. 2015;143:77-82.
    Abstract     Related articles   

  122. HUPE MC, Kramer MW, Kuczyk MA, Merseburger AS, et al
    [Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?].
    Aktuelle Urol. 2015;46:242-7.
    Abstract     Related articles   

  123. MAYR R, Pycha A
    [Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer].
    Aktuelle Urol. 2015;46:236-41.
    Abstract     Related articles   

  124. ERBEN P, Hartmann A, Bolenz C
    [Molecular Characterisation of Urothelial Bladder Cancer: Will it Improve Patient Care?].
    Aktuelle Urol. 2015;46:227-35.
    Abstract     Related articles   

  125. HARA T, Matsuyama H, Kamiryo Y, Hayashida S, et al
    Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged >/=75 years after radical cystectomy for treatment of bladder cancer.
    Int J Clin Oncol. 2015.
    Abstract     Related articles   

  126. POMMIER JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, et al
    Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Infect Dis (Lond). 2015.
    Abstract     Related articles   

  127. CHATTA D, Cottrell L, Burnett B, Laverty G, et al
    The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer.
    J Pharm Pharmacol. 2015 Jun 16. doi: 10.1111/jphp.12441.
    Abstract     Related articles   

  128. KIM YW, Yoon HY, Seo SP, Lee SK, et al
    Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer.
    Dis Markers. 2015;2015:402963.
    Abstract     Related articles   

  129. CHEN CL, Liu CY, Cha TL, Hsu CY, et al
    Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
    J Chin Med Assoc. 2015 Jun 11. pii: S1726-4901(15)00119.
    Abstract     Related articles   

  130. WANG G, Lam KM, Deng Z, Choi KS, et al
    Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques.
    Comput Biol Med. 2015;63:124-132.
    Abstract     Related articles   

  131. DU Y, Wang Y, Zhang F, Wu W, et al
    Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
    Tumour Biol. 2015.
    Abstract     Related articles   

  132. CODOLO G, Munari F, Fassan M, de Bernard M, et al
    Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model.
    J Vis Exp. 2015;.
    Abstract     Related articles   

  133. WAN GX, Chen P, Yu XJ, Di QS, et al
    Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.
    Int J Clin Exp Med. 2015;8:3935-45.
    Abstract     Related articles   

  134. GUO B, Che T, Shi B, Guo L, et al
    Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer.
    Int J Clin Exp Med. 2015;8:3619-28.
    Abstract     Related articles   

  135. KHMELEVSKY EV, Bychkova NM
    [Radiosensitivity of bone metastases from tumors in different primary sites].
    Vopr Onkol. 2015;61:77-84.
    Abstract     Related articles   

  136. CHA EK, Donahue TF, Bochner BH
    Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?
    Urol Clin North Am. 2015;42:189-99.
    Abstract     Related articles   

  137. WEN J, Li HZ, Ji ZG, Jin J, et al
    Effects of sunitinib malate on growth of human bladder transitional cell line T24 in vitro.
    Chin Med Sci J. 2015;30:51-5.
    Abstract     Related articles   

  138. SERONT E, Machiels JP
    Molecular biology and targeted therapies for urothelial carcinoma.
    Cancer Treat Rev. 2015;41:341-53.
    Abstract     Related articles   

  139. BARABAS-HAJDU E, Maier A, Coros F, Martha O, et al
    Retrovesical hydatidosis associated with urinary tract pathology - case report.
    Acta Microbiol Immunol Hung. 2015;62:21-7.
    Abstract     Related articles   

  140. WANG HJ, Pui MH, Guo Y, Li SR, et al
    Multiparametric 3-T MRI for Differentiating Low-Versus High-Grade and Category T1 Versus T2 Bladder Urothelial Carcinoma.
    AJR Am J Roentgenol. 2015;204:330-334.
    Abstract     Related articles   

  141. MATSUMOTO R, Takada N, Abe T, Minami K, et al
    Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  142. TIAN YF, Tang K, Guan W, Yang T, et al
    OK-432 Suppresses Proliferation and Metastasis by Tumor Associated Macrophages in Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:4537-42.
    Abstract     Related articles   

  143. GARCIA-CUESTA EM, Lopez-Cobo S, Alvarez-Maestro M, Esteso G, et al
    NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.
    Front Immunol. 2015;6:284.
    Abstract     Related articles   

  144. EISSA S, Matboli M, Shawky S, Essawy NO, et al
    Urine biomarkers of schistosomiais and its associated bladder cancer.
    Expert Rev Anti Infect Ther. 2015.
    Abstract     Related articles   

    Molecular Biomarkers in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:705-6.
    Abstract     Related articles   

  146. SOUSA A, Pineiro I, Aparici V, Neira P, et al
    Analysis of Budgetary Impact of moderate and high risk non muscle-invasive bladder cancer by means of neoadjuvant hyperthermia chemotherapy compared to the standard adjuvant treatment with BCG.
    Arch Esp Urol. 2015;68:482-492.
    Abstract     Related articles   

  147. KATO T, Nomura K, Kondo F, Wakisaka M, et al
    Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer.
    ScientificWorldJournal. 2015;2015:325305.
    Abstract     Related articles   

  148. MANI J, Antonietti P, Rakel S, Blaheta R, et al
    Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737.
    World J Urol. 2015.
    Abstract     Related articles   

    Commentary on "Racial variation in the quality of surgical care for bladder cancer." Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA Jr, Penson DF, Department of Urologic Surgery, Vanderbilt Unive
    Urol Oncol. 2015 Jun 19. pii: S1078-1439(15)00223.
    Abstract     Related articles   

  150. RYBOTYCKA Z, Dlugosz A
    [Diagnostic significance of protein NMP22 in bladder cancer].
    Pol Merkur Lekarski. 2015;38:309-14.
    Abstract     Related articles   

  151. MAZZOLA CR, Chin J
    Targeting the VEGF pathway in metastatic bladder cancer.
    Expert Opin Investig Drugs. 2015;24:913-27.
    Abstract     Related articles   

  152. AMANTINI C, Morelli MB, Santoni M, Soriani A, et al
    Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.
    Oncoscience. 2015;2:395-409.
    Abstract     Related articles   

  153. LUTKENHAUS LJ, Visser J, de Jong R, Hulshof MC, et al
    Evaluation of delivered dose for a clinical daily adaptive plan selection strategy for bladder cancer radiotherapy.
    Radiother Oncol. 2015 Jun 18. pii: S0167-8140(15)00282.
    Abstract     Related articles   

  154. SHEVCHENKO AN, Shihjarova AI, Filatova EV, Tarnopol'skaja OV, et al
    Urologiia. 2015;:54-7.
    Abstract     Related articles   

  155. KAYNAR M, Goktas S
    Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Urol Oncol. 2015 Jun 16. pii: S1078-1439(15)00241.
    Abstract     Related articles   

  156. HE YD, Luo ZH, Yang M, Ruan XX, et al
    Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder.
    Biochem Biophys Res Commun. 2015;459:416-23.
    Abstract     Related articles   

  157. TANG Y, Zhang X, Qi F, Chen M, et al
    Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line.
    Exp Ther Med. 2015;9:1851-1856.
    Abstract     Related articles   

  158. TABATA M, Ikeda M, Urakami S, Takahashi S, et al
    Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  159. WANG X, Wu G, Cao G, Yang L, et al
    Zoledronic acid inhibits the pentose phosphate pathway through attenuating the RasTAp73G6PD axis in bladder cancer cells.
    Mol Med Rep. 2015 Jun 24. doi: 10.3892/mmr.2015.3995.
    Abstract     Related articles   

  160. DANCIK GM
    An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer.
    BMC Urol. 2015;15:59.
    Abstract     Related articles   

  161. KIM WJ
    Is 5 -AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?
    Int Neurourol J. 2015;19:55-66.
    Abstract     Related articles   

  162. SHI H, Jiang H, Wang L, Cao Y, et al
    Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.
    Cell Cycle. 2015.
    Abstract     Related articles   

  163. RUDZINSKI JK, Basappa NS, North S
    Perioperative chemotherapy for muscle invasive bladder cancer.
    Curr Opin Support Palliat Care. 2015.
    Abstract     Related articles   

  164. XIAO X, Ma G, Li S, Wang M, et al
    Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.
    Sci Rep. 2015;5:11751.
    Abstract     Related articles   

  165. ROSE TL, Deal AM, Basch E, Godley PA, et al
    Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings.
    Urol Oncol. 2015 Jun 26. pii: S1078-1439(15)00272.
    Abstract     Related articles   

  166. CHEN GF, Shi TP, Wang BJ, Wang XY, et al
    J Biol Regul Homeost Agents. 2015;29:465-70.
    Abstract     Related articles   

  167. MORICEAU G, Vallard A, Rivoirard R, Mery B, et al
    Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical Trials.
    Clin Genitourin Cancer. 2015 Jun 6. pii: S1558-7673(15)00122.
    Abstract     Related articles   

  168. LEO E, Molinari AL, Rossi G, Ferrari SA, et al
    Mycotic abdominal aortic aneurysm following adjuvant therapy with bacillus Calmette-Guerin (BCG) in patients with urothelial bladder cancer. A rare but misinterpreted complication.
    Ann Vasc Surg. 2015 Jun 23. pii: S0890-5096(15)00396.
    Abstract     Related articles   

  169. AHMED M, Kanji A, Begum T
    Gynaecomastia: an unusual presenting symptom of bladder cancer.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  170. KUMAR A
    A retained catheter in the radial artery.
    J Perioper Pract. 2015;25:39.
    Abstract     Related articles   

  171. MILOSEVIC R, Milovic N, Aleksic P, Lazic M, et al
    Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guerin.
    Vojnosanit Pregl. 2015;72:241-6.
    Abstract     Related articles   

  172. BANCEVIC V, Aleksic P, Milovic N, Spasic A, et al
    Radical cystectomy in eldery.
    Vojnosanit Pregl. 2015;72:136-9.
    Abstract     Related articles   

  173. DE SOUZA D, Mariano DO, Nedel F, Schultze E, et al
    New organochalcogen multitarget drug: synthesis and antioxidant and antitumoral activities of chalcogenozidovudine derivatives.
    J Med Chem. 2015;58:3329-39.
    Abstract     Related articles   

  174. OJERHOLM E, Stripp D, Mamtani R, Van Arsdalen K, et al
    Angiosarcoma of the bladder following prostate radiotherapy.
    Am J Med. 2015;128:e11-2.
    Abstract     Related articles   

  175. WANG H, Zhang W, Zuo Y, Ding M, et al
    miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  176. Bladder cancer: Metformin reduces recurrence after radical cystectomy.
    Nat Rev Urol. 2015 Jul 7. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  177. SABBINENI H, Alwhaibi A, Goc A, Gao F, et al
    Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.
    Eur J Pharmacol. 2015 Jul 3. pii: S0014-2999(15)30124.
    Abstract     Related articles   

  178. JEONG JW, Lee WS, Go SI, Nagappan A, et al
    Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members.
    Phytother Res. 2015 Jul 7. doi: 10.1002/ptr.5402.
    Abstract     Related articles   

  179. EAPEN L
    A review of the 2014 English Language publications pertinent to the treatment of invasive bladder cancer by radiotherapy.
    Curr Opin Support Palliat Care. 2015.
    Abstract     Related articles   

  180. SHERIF A, Hasan MN, Radecka E, Rodriguez AL, et al
    Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer.
    Scand J Urol. 2015.
    Abstract     Related articles   

  181. LI C, Wu S, Wang H, Bi X, et al
    The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  182. EISSA S, Matboli M, Essawy NO, Kotb YM, et al
    Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Tumour Biol. 2015.
    Abstract     Related articles   

  183. GUO LS, Li HX, Li CY, Zhang SY, et al
    Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
    Pharmazie. 2015;70:123-8.
    Abstract     Related articles   

  184. KANG M, Jeong CW, Kwak C, Kim HH, et al
    The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Yonsei Med J. 2015;56:375-81.
    Abstract     Related articles   

  185. SCHULZ WA, Koutsogiannouli EA, Niegisch G, Hoffmann MJ, et al
    Epigenetics of urothelial carcinoma.
    Methods Mol Biol. 2015;1238:183-215.
    Abstract     Related articles   

  186. MOORE JH
    Epistasis analysis using ReliefF.
    Methods Mol Biol. 2015;1253:315-25.
    Abstract     Related articles   

  187. MOORE JH, Andrews PC
    Epistasis analysis using multifactor dimensionality reduction.
    Methods Mol Biol. 2015;1253:301-14.
    Abstract     Related articles   

  188. MOORE JH, Hu T
    Epistasis analysis using information theory.
    Methods Mol Biol. 2015;1253:257-68.
    Abstract     Related articles   

  189. KIM HS, Piao S, Moon KC, Jeong CW, et al
    Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer.
    J Cancer. 2015;6:750-758.
    Abstract     Related articles   

  190. YUGE K, Kikuchi E, Hagiwara M, Yasumizu Y, et al
    Nicotine induces tumor growth and chemoresistance through activation of PI3K/Akt/mTOR pathway in bladder cancer.
    Mol Cancer Ther. 2015 Jul 16. pii: molcanther.0140.2015.
    Abstract     Related articles   

  191. VAN DE PUTTE EE, Mertens LS, Meijer RP, van der Heijden MS, et al
    Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.
    World J Urol. 2015.
    Abstract     Related articles   

  192. MORALES A, Kamat A, Steinberg G, Given R, et al
    Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4).
    Urol Oncol. 2015;33:335-336.
    Abstract     Related articles   

  193. BOOTH CM, Tannock IF
    Benefits of Adjuvant Chemotherapy for Bladder Cancer.
    JAMA Oncol. 2015 Jun 25. doi: 10.1001/jamaoncol.2015.1210.
    Abstract     Related articles   

  194. MIN X, Zhuang Y, Zhang Z, Jia Y, et al
    Lab in a Tube: Sensitive Detection of MicroRNAs in Urine Samples from Bladder Cancer Patients Using a Single-label DNA Probe with AIEgens.
    ACS Appl Mater Interfaces. 2015.
    Abstract     Related articles   

  195. VASEKAR M, Degraff D, Joshi M
    Immunotherapy in Bladder Cancer.
    Curr Mol Pharmacol. 2015.
    Abstract     Related articles   

  196. KONAC E, Varol N, Kiliccioglu I, Bilen CY, et al
    Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells.
    Oncol Lett. 2015;10:560-564.
    Abstract     Related articles   

  197. AI X, Jia ZM, Wang J, DI GP, et al
    Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.
    Oncol Lett. 2015;10:543-549.
    Abstract     Related articles   

  198. LAN G, Yang L, Xie X, Peng L, et al
    MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.
    Arch Med Sci. 2015;11:561-9.
    Abstract     Related articles   

  199. LIU Y, Baker S, Jiang H, Stuart G, et al
    Correlating Bladder Cancer Risk Genes with Their Targeting MicroRNAs Using MMiRNA-Tar.
    Genomics Proteomics Bioinformatics. 2015 Jul 10. pii: S1672-0229(15)00052.
    Abstract     Related articles   

  200. BOTELHO MC, Figueiredo J, Alves H
    Bladder cancer and urinary Schistosomiasis in Angola.
    J Nephrol Res. 2015;1:22-24.
    Abstract     Related articles   

  201. LISS MA, Noguchi J, Lee HJ, Vera DR, et al
    Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update.
    Indian J Urol. 2015;31:170-5.
    Abstract     Related articles   

  202. LI S, Yu Z, Chen SS, Li F, et al
    The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.
    Urol Oncol. 2015 Jul 8. pii: S1078-1439(15)00291.
    Abstract     Related articles   

  203. FAMULARO G, Stasolla A, Gasbarrone L
    Pachydermoperiostosis and bladder cancer.
    Dermatol Online J. 2015;21.
    Abstract     Related articles   

  204. SHUKLA HS, Sirohi B, Behari A, Sharma A, et al
    Indian Council of Medical Research consensus document for the management of gall bladder cancer.
    Indian J Med Paediatr Oncol. 2015;36:79-84.
    Abstract     Related articles   

  205. YANG X, Ou L, Tang M, Wang Y, et al
    Knockdown of PLCepsilon inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  206. OUYANG Q, Duan Z, Jiao G, Lei J, et al
    A Biomimic Reconstituted High-Density-Lipoprotein-Based Drug and p53 Gene Co-delivery System for Effective Antiangiogenesis Therapy of Bladder Cancer.
    Nanoscale Res Lett. 2015;10:965.
    Abstract     Related articles   

  207. ZHUANG J, Lu Q, Shen B, Huang X, et al
    TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
    Sci Rep. 2015;5:11924.
    Abstract     Related articles   

  208. KAO HL, Lai CR, Ho HL, Pan CC, et al
    Molecular Typing for Detection of High-Risk HPV is a Useful Tool to Distinguish Primary Bladder Cancer from Secondary Involvement of Uterine Cervical Cancer in the Urinary Bladder.
    Histopathology. 2015 Jul 7. doi: 10.1111/his.12769.
    Abstract     Related articles   

  209. KESSLER ER, Amini A, Wilson SS, Anp-C KB, et al
    Lymphoepithelioma-Like Carcinoma of the Urinary Bladder.
    Oncology (Williston Park). 2015;29:462.
    Abstract     Related articles   

  210. SOLOMON JP, Hansel DE
    Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates.
    Adv Anat Pathol. 2015;22:102-12.
    Abstract     Related articles   

  211. MAGRATH GN, Proctor CM, Reardon WA, Patel KG, et al
    Esophageal adenocarcinoma and urothelial carcinoma orbital metastases masquerading as infection.
    Orbit. 2015;34:51-5.
    Abstract     Related articles   

  212. SAWICKA E, Lisowska A, Kowal P, Dlugosz A, et al
    The role of oxidative stress in bladder cancer.
    Postepy Hig Med Dosw (Online). 2015;69:744-52.
    Abstract     Related articles   

  213. HADJIISKI L, Weizer AZ, Alva A, Caoili EM, et al
    Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.
    AJR Am J Roentgenol. 2015;205:348-52.
    Abstract     Related articles   

  214. JANCKE G, Rosell J, Jahnson S
    Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence.
    Scand J Urol. 2015.
    Abstract     Related articles   

  215. WISE J
    No strong association is found between pioglitazone and bladder cancer.
    BMJ. 2015;351:h3934.
    Abstract     Related articles   

  216. IZARD JP, Siemens DR, Mackillop WJ, Wei X, et al
    Outcomes of squamous histology in bladder cancer: A population-based study.
    Urol Oncol. 2015 Jul 18. pii: S1078-1439(15)00299.
    Abstract     Related articles   

  217. SIEMENS DR, Mackillop WJ, Peng Y, Wei X, et al
    Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study.
    Urol Oncol. 2015 Jul 18. pii: S1078-1439(15)00293.
    Abstract     Related articles   

  218. KONSTANTAKOU EG, Voutsinas GE, Velentzas AD, Basogianni AS, et al
    3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
    Mol Cancer. 2015;14:135.
    Abstract     Related articles   

  219. LIU C, Chen Z, Fang J, Xu A, et al
    H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation.
    Tumour Biol. 2015.
    Abstract     Related articles   

  220. TIAN F, Xing X, Xu F, Cheng W, et al
    Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer.
    Cancer Biother Radiopharm. 2015.
    Abstract     Related articles   

  221. LEWIS JD, Habel LA, Quesenberry CP, Strom BL, et al
    Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.
    JAMA. 2015;314:265-77.
    Abstract     Related articles   

  222. WIECZOREK E, Jablonowski Z, Tomasik B, Konecki T, et al
    MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Clin Biochem. 2015 Jul 18. pii: S0009-9120(15)00301.
    Abstract     Related articles   

  223. AZEVEDO R, Ferreira JA, Peixoto A, Neves M, et al
    Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.
    J Control Release. 2015 Jul 18. pii: S0168-3659(15)30016.
    Abstract     Related articles   

  224. STONE L
    Bladder cancer: Cancer cell sampling and storage-new filtration device aids collection from urine.
    Nat Rev Urol. 2015 Jul 21. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  225. ZHANG MN, Ding Z, Long YT
    Sensing cisplatin-induced permeation of single live human bladder cancer cells by scanning electrochemical microscopy.
    Analyst. 2015.
    Abstract     Related articles   

  226. DU HF, Ou LP, Lv CK, Yang X, et al
    Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/beta-catenin -dependent pathway in vitro and in vivo.
    Cancer Biol Ther. 2015.
    Abstract     Related articles   

  227. MILOWICH D, Le Mercier M, De Neve N, Sandras F, et al
    Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study.
    Springerplus. 2015;4:349.
    Abstract     Related articles   

  228. TANG K, Wang C, Chen Z, Xu H, et al
    Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Int J Clin Exp Pathol. 2015;8:4999-5007.
    Abstract     Related articles   

  229. GARCIA PV, Apolinario LM, Bockelmann PK, Nunes Ida S, et al
    Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
    Int J Clin Exp Pathol. 2015;8:4427-43.
    Abstract     Related articles   

  230. MILOJEVIC B, Dzamic Z, Kajmakovic B, Milenkovic Petronic D, et al
    Urothelial carcinoma: Recurrence and risk factors.
    J BUON. 2015;20:391-8.
    Abstract     Related articles   

  231. BOSMAN FT
    In this issue.
    Virchows Arch. 2015;466:483.
    Abstract     Related articles   

  232. MATA DA, Groshen S, Von Rundstedt FC, Skinner DG, et al
    Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
    J Surg Oncol. 2015;111:923-8.
    Abstract     Related articles   

  233. DELL'ATTI L
    Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
    Arch Ital Urol Androl. 2015;87:76-9.
    Abstract     Related articles   

  234. FONSEKA T, Ahmed K, Froghi S, Khan SA, et al
    Comparing robotic, laparoscopic and open cystectomy: a systematic review and meta-analysis.
    Arch Ital Urol Androl. 2015;87:41-8.
    Abstract     Related articles   

  235. ZAKARIA AS, Santos F, Tanguay S, Kassouf W, et al
    Radical cystectomy in patients over 80 years old in Quebec: A population-based study of outcomes.
    J Surg Oncol. 2015;111:917-22.
    Abstract     Related articles   

  236. DI CARLO D, Ferrari A, Perruccio K, D'Angelo P, et al
    Management and follow-up of urothelial neoplasms of the bladder in children: a report from the TREP project.
    Pediatr Blood Cancer. 2015;62:1000-3.
    Abstract     Related articles   

  237. WARRICK JI, Hovelson DH, Amin A, Liu CJ, et al
    Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.
    Virchows Arch. 2015;466:297-311.
    Abstract     Related articles   

  238. SINGH PK, Srivastava AK, Dalela D, Rath SK, et al
    Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Immunobiology. 2015;220:68-73.
    Abstract     Related articles   

  239. SINGH PK, Srivastava AK, Rath SK, Dalela D, et al
    Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Immunobiology. 2015;220:103-8.
    Abstract     Related articles   

  240. ZHANG Z, Zhang C, Wu C, Yang B, et al
    Progressive ureteral dilations and retrograde placement of single-j stent guided by flexible cystoscope for management of ureteroenteral anastomotic stricture in patients after radical cystectomy and bricker urinary diversion.
    J Endourol. 2015;29:90-4.
    Abstract     Related articles   

  241. MAKAMBI KH, Seung H
    A non-iterative extension of the multivariate random effects meta-analysis.
    J Biopharm Stat. 2015;25:109-23.
    Abstract     Related articles   

  242. DE CASTRO ABREU AL, Azhar RA, Berger AK, Chopra S, et al
    Robotic implantation of biodegradable regenerative urinary conduit: experimental study.
    J Endourol. 2015;29:52-7.
    Abstract     Related articles   

  243. STOKKEVAG CH, Engeseth GM, Hysing LB, Ytre-Hauge KS, et al
    Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  244. LEI M, Xie W, Sun E, Sun Y, et al
    microRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer.
    DNA Cell Biol. 2015.
    Abstract     Related articles   

  245. LOMBARD AP, Mudryj M
    The emerging role of the androgen receptor in bladder cancer.
    Endocr Relat Cancer. 2015 Jul 30. pii: ERC-15-0209.
    Abstract     Related articles   

  246. DE PAOLI M, Perco P, Muhlberger I, Lukas A, et al
    Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic.
    Biomarkers. 2015.
    Abstract     Related articles   

  247. NAKAI Y, Tatsumi Y, Miyake M, Anai S, et al
    Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.
    Photodiagnosis Photodyn Ther. 2015 Jul 27. pii: S1572-1000(15)30012.
    Abstract     Related articles   

  248. KAPOOR VK
    Is gall bladder cancer a bad cancer per se?
    World J Gastrointest Surg. 2015;7:107-9.
    Abstract     Related articles   

  249. SUN E, Zhang W, Wang L, Wang A, et al
    Down-regulation of Sphk2 suppresses bladder cancer progression.
    Tumour Biol. 2015.
    Abstract     Related articles   

  250. ALIRAMAJI A, Kaseean A, Yousefnia Pasha YR, Shafi H, et al
    Age distribution types of bladder cancers and their relationship with opium consumption and smoking.
    Caspian J Intern Med. 2015;6:82-6.
    Abstract     Related articles   

  251. COMPLOJ E, Trenti E, Palermo S, Pycha A, et al
    Urinary cytology in bladder cancer: why is it still relevant?
    Urologia. 2015;0:0.
    Abstract     Related articles   

  252. KRPINA K, Babarovic E, Jonjic N
    Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.
    Virchows Arch. 2015.
    Abstract     Related articles   

  253. XIE XF, Ding Q, Hou JG, Chen G, et al
    Inhibitory effects of a dendritic cell vaccine loaded with radiation-induced apoptotic tumor cells on tumor cell antigens in mouse bladder cancer.
    Genet Mol Res. 2015;14:7548-55.
    Abstract     Related articles   

  254. FU X, Pang X, Qi H, Chen S, et al
    XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
    Clin Transl Oncol. 2015.
    Abstract     Related articles   

  255. OZTURK H
    Comparing RECIST with EORTC criteria in metastatic bladder cancer.
    J Cancer Res Clin Oncol. 2015.
    Abstract     Related articles   

  256. PACELLA E, Ricci F, Colecchia M, Boccardo F, et al
    Prostatic and urothelial metastasis in the same lymph node: a case report.
    Anal Quant Cytopathol Histpathol. 2015;37:139-43.
    Abstract     Related articles   

  257. BRACARDA S, Altavilla A, Hamzaj A, Sisani M, et al
    Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.
    Semin Oncol. 2015;42:495-505.
    Abstract     Related articles   

  258. PAPADOPOULOS EI, Yousef GM, Scorilas A
    Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Tumour Biol. 2015;36:3197-207.
    Abstract     Related articles   

  259. LI X, Liu S, Yao S, Wang M, et al
    A Rare Case of Urachal Mucinous Adenocarcinoma Detected by 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  260. ZAGOURI F, Peroukidis S, Tzannis K, Kouloulias V, et al
    Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: a systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG).
    Crit Rev Oncol Hematol. 2015;93:36-49.
    Abstract     Related articles   

  261. GRONBORG C, Vestergaard A, Hoyer M, Sohn M, et al
    Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  262. POYET C, Buser L, Roudnicky F, Detmar M, et al
    Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.
    J Clin Pathol. 2015 Aug 6. pii: jclinpath-2015-202898.
    Abstract     Related articles   

  263. JEONG P, Ha YS, Yun SJ, Yoon HY, et al
    Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis.
    BMC Urol. 2015;15:80.
    Abstract     Related articles   

  264. MASIOR L, Krasnodebski M, Kobryn K, Grat M, et al
    Surgical treatment of gall-bladder cancer.
    Pol Przegl Chir. 2015;87:324-30.
    Abstract     Related articles   

  265. KIM GY, Park SY, Jo A, Kim M, et al
    Gecko proteins induce the apoptosis of bladder cancer 5637 cell by inhibiting Akt and activating intrinsic caspase cascade.
    BMB Rep. 2015 Aug 7. pii: 3261.
    Abstract     Related articles   

  266. PANG X, Fu X, Chen S, Zhu X, et al
    Overexpression of CIP2A promotes bladder cancer progression by regulating EMT.
    Clin Transl Oncol. 2015.
    Abstract     Related articles   

  267. NOSOV AK, Reva SA, Dzhalilov IB, Petrov SB, et al
    Vopr Onkol. 2015;61:352-61.
    Abstract     Related articles   

  268. BENOIT T, Keller EX, Wolfsgruber P, Hermanns T, et al
    High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.
    Med Sci Monit. 2015;21:2266-74.
    Abstract     Related articles   

  269. KIM SH, Seo HK, Shin HC, Chang SJ, et al
    Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
    J Korean Med Sci. 2015;30:1150-6.
    Abstract     Related articles   

  270. CHEN Z, Li Q, Wang S, Zhang J, et al
    miR4855p inhibits bladder cancer metastasis by targeting HMGA2.
    Int J Mol Med. 2015 Aug 3. doi: 10.3892/ijmm.2015.2302.
    Abstract     Related articles   

  271. HUANG J, Wu Z, Wang G, Cai Y, et al
    NMyc downstreamregulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.
    Mol Med Rep. 2015 Aug 3. doi: 10.3892/mmr.2015.4169.
    Abstract     Related articles   

  272. SANTOS F, Dragomir A, Zakaria AS, Kassouf W, et al
    Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.
    BMC Health Serv Res. 2015;15:308.
    Abstract     Related articles   

  273. WANG S, Qi X, Liu F, Zheng M, et al
    An improved technique for bladder cancer: Pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples.
    Eur J Surg Oncol. 2015 Jul 26. pii: S0748-7983(15)00524.
    Abstract     Related articles   

  274. ZUBKOV AJ, Sitdykov JN, Nuriev LR, Sitdykova MJ, et al
    Urologiia. 2015;:65-7.
    Abstract     Related articles   

  275. SHEN HM, D'Souza AM, Green IF, Pohar KS, et al
    Do amount of variant differentiation and mitotic rate in bladder cancer change with neoadjuvant chemotherapy?
    Hum Pathol. 2015 Jun 4. pii: S0046-8177(15)00196.
    Abstract     Related articles   

  276. RAUSCH S, Hennenlotter J, Teepe K, Kuehs U, et al
    Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
    Urol Oncol. 2015 Jul 28. pii: S1078-1439(15)00295.
    Abstract     Related articles   

  277. FARRAG HA, A-Karam El-Din A, Mohamed El-Sayed ZG, Abdel-Latifissa S, et al
    Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis.
    Int J Radiat Biol. 2015;91:519-27.
    Abstract     Related articles   

  278. VAROL N, Konac E, Bilen CY
    Does Wnt/beta-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
    Exp Biol Med (Maywood). 2015;240:624-30.
    Abstract     Related articles   

  279. PICKENS RB, Bajo A, Simaan N, Herrell D, et al
    A pilot ex vivo evaluation of a telerobotic system for transurethral intervention and surveillance.
    J Endourol. 2015;29:231-4.
    Abstract     Related articles   

    Cellular swirls and cellular swirl-like structures are not restricted to papillary thyroid carcinoma.
    Diagn Cytopathol. 2014 Feb 18. doi: 10.1002/dc.23108.
    Abstract     Related articles   

  281. CHOU R, Selph S, Buckley D, Gustafson K, et al
    Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages.
    Am J Cancer Res. 2015;5:2090-7.
    Abstract     Related articles   

  282. QIE Y, Hu H, Tian D, Xie L, et al
    [The value of taking surgical margin specimens during transurethral resection of bladder tumor in the diagnosis and treatment of non-muscle invasive bladder cancer].
    Zhonghua Wai Ke Za Zhi. 2015;53:202-205.
    Abstract     Related articles   

  283. WEISS BE, Pietzak EJ, Wein AJ, Malkowicz SB, et al
    Single instillation of mitomycin C plus bacillus Calmette-Guerin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer.
    Can J Urol. 2015;22:7876-81.
    Abstract     Related articles   

  284. KRABBE LM, Westerman ME, Margulis V, Raj GV, et al
    Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Can J Urol. 2015;22:7865-75.
    Abstract     Related articles   

  285. FAHMY O, Asri K, Schwentner C, Stenzl A, et al
    Current status of robotic assisted radical cystectomy with intracorporeal ileal neobladder for bladder cancer.
    J Surg Oncol. 2015 Aug 11. doi: 10.1002/jso.24007.
    Abstract     Related articles   

  286. SHANG Z, Li Y, Zhang M, Tian J, et al
    Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9(R) enhances BCG efficacy to better suppress bladder cancer progression.
    Mol Cancer Ther. 2015 Aug 11. pii: molcanther.1055.2014.
    Abstract     Related articles   

  287. NESI G, Nobili S, Cai T, Caini S, et al
    Chronic inflammation in urothelial bladder cancer.
    Virchows Arch. 2015.
    Abstract     Related articles   

  288. HAYAKAWA N, Kikuno N, Ishihara H, Ryoji O, et al
    Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10-year, single center experience.
    Springerplus. 2015;4:401.
    Abstract     Related articles   

  289. SUNDARARAJAN S, Vogelzang NJ
    Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
    Future Oncol. 2015;11:2299-306.
    Abstract     Related articles   

  290. SCHMID SC, Zahel T, Haller B, Horn T, et al
    Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.
    World J Urol. 2015.
    Abstract     Related articles   

  291. SAAD F
    Progress in bladder cancer: is there light at the end of the tunnel?
    Curr Opin Support Palliat Care. 2015;9:244.
    Abstract     Related articles   

    Bilateral Iritis after Vaccine for Bladder Cancer.
    Optom Vis Sci. 2015.
    Abstract     Related articles   

  293. GOOSSENS ME, Buntinx F, Zeegers MP, Driessen JH, et al
    Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients.
    Br J Clin Pharmacol. 2015 Aug 10. doi: 10.1111/bcp.12740.
    Abstract     Related articles   

  294. SEASTEDT KP, Ahmad U, Lau C, Ruggeri-Weigel P, et al
    Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette-Guerin Treatment.
    Ann Thorac Surg. 2015;99:2210-2.
    Abstract     Related articles   

  295. KAZI TG, Wadhwa SK, Afridi HI, Talpur FN, et al
    Comparison of essential and toxic elements in esophagus, lung, mouth and urinary bladder male cancer patients with related to controls.
    Environ Sci Pollut Res Int. 2015;22:7705-15.
    Abstract     Related articles   

  296. CONDE VR, Alves MG, Oliveira PF, Silva BM, et al
    Tea (Camellia sinensis (L.)): a putative anticancer agent in bladder carcinoma?
    Anticancer Agents Med Chem. 2015;15:26-36.
    Abstract     Related articles   

  297. LU B, Liang Y
    Pagetoid spread of bladder urothelial carcinoma to the vagina and vulva.
    J Low Genit Tract Dis. 2015;19:e13-6.
    Abstract     Related articles   

  298. YAO K, He L, Gan Y, Zeng Q, et al
    MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
    Diagn Pathol. 2015;10:146.
    Abstract     Related articles   

  299. CHEN YZ, Li J, Zhao YX, Liu D, et al
    Retraction Note to: Genetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis.
    Mol Biol Rep. 2015.
    Abstract     Related articles   

  300. HERR HW
    Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1041-6.
    Abstract     Related articles   

  301. POLI G, Brancorsini S, Cochetti G, Barillaro F, et al
    Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA.
    Urol Oncol. 2015 Aug 14. pii: S1078-1439(15)00355.
    Abstract     Related articles   

  302. FRANZEN CA, Blackwell RH, Todorovic V, Greco KA, et al
    Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes.
    Oncogenesis. 2015;4:e163.
    Abstract     Related articles   

  303. ZHAI N, Wang YH, Zhu LM, Wang JH, et al
    Sensitivity and Specificity of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Bladder Cancers.
    Clin Invest Med. 2015;38:E173-84.
    Abstract     Related articles   

  304. LIU NW, Shatagopam K, Monn MF, Kaimakliotis HZ, et al
    Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series.
    Urol Oncol. 2015 Aug 13. pii: S1078-1439(15)00350.
    Abstract     Related articles   

  305. QU H, Ma B, Yuan HF, Wang ZY, et al
    Effect of salinomycin on metastasis and invasion of bladder cancer cell line T24.
    Asian Pac J Trop Med. 2015;8:578-82.
    Abstract     Related articles   

  306. VEERANKI OL, Bhattacharya A, Tang L, Marshall JR, et al
    Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.
    Curr Pharmacol Rep. 2015;1:272-282.
    Abstract     Related articles   

  307. CHOU R, Selph S, Buckley D, Gustafson K, et al
    Improved Target Cell Selection and Counting Method for UroVysion Fluorescence in Situ Hybridization.
    Clin Lab. 2015;61.
    Abstract     Related articles   

  308. LOPEZ-BELTRAN A, Marques RC, Montironi R, Reymundo C, et al
    Dysplasia and carcinoma in situ of the urinary bladder.
    Anal Quant Cytopathol Histpathol. 2015;37:29-38.
    Abstract     Related articles   

  309. LOPEZ-BELTRAN A, Marques RC, Montironi R, Reymundo C, et al
    Rare entities in urinary bladder pathology.
    Anal Quant Cytopathol Histpathol. 2015;37:14-22.
    Abstract     Related articles   

  310. BOLLINENI VR, Kramer G, Liu Y, Melidis C, et al
    A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.
    Cancer Treat Rev. 2015;41:496-502.
    Abstract     Related articles   

  311. GHORBANZADEH-MOGHADDAM A, Gholamrezaei A, Hemati S
    Vitamin D Deficiency Is Associated With the Severity of Radiation-Induced Proctitis in Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2015;92:613-8.
    Abstract     Related articles   

  312. BRETLAU T, Hansen RH, Thomsen HS
    CT urography and hematuria: a retrospective analysis of 771 patients undergoing CT urography over a 1-year period.
    Acta Radiol. 2015;56:890-6.
    Abstract     Related articles   

  313. GRONBORG C, Vestergaard A, Hoyer M, Sohn M, et al
    Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  314. GONG Y, Qiu W, Ning X, Yang X, et al
    CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Oncotarget. 2015.
    Abstract     Related articles   

  315. WANG X, Wu Q, Xu B, Wang P, et al
    MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.
    FEBS J. 2015 Aug 27. doi: 10.1111/febs.13502.
    Abstract     Related articles   

  316. HRUDEY SE, Backer LC, Humpage AR, Krasner SW, et al
    Evaluating Evidence for Association of Human Bladder Cancer with Drinking-Water Chlorination Disinfection By-Products.
    J Toxicol Environ Health B Crit Rev. 2015.
    Abstract     Related articles   

  317. OU Z, Wang Y, Liu L, Li L, et al
    Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.
    Oncotarget. 2015.
    Abstract     Related articles   

  318. NOGUCHI JL, Liss MA, Parsons JK
    Obesity, Physical Activity and Bladder Cancer.
    Curr Urol Rep. 2015;16:546.
    Abstract     Related articles   

  319. GRIGOR'EV EG, Frolova IG, Velichko SA
    [Lieutaud's triangle lesion and urodynamic disorders in bladder cancer according to magnetic resonance imaging data].
    Vestn Rentgenol Radiol. 2015;:31-6.
    Abstract     Related articles   

  320. TAOKA Y, Matsumoto K, Ohashi K, Minamida S, et al
    Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis.
    Biomed Res. 2015;36:253-61.
    Abstract     Related articles   

  321. RYK C, Koskela LR, Thiel T, Wiklund NP, et al
    Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
    Redox Biol. 2015;6:REDOXD1500063.
    Abstract     Related articles   

  322. ALJABERY F, Lindblom G, Skoog S, Shabo I, et al
    PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.
    BMC Urol. 2015;15:87.
    Abstract     Related articles   

  323. CHOU R, Selph S, Buckley D, Gustafson K, et al
    J Ayub Med Coll Abbottabad. 2015;27:131-4.
    Abstract     Related articles   

  324. KIMURA H, Murakami K, Aoyama T, Koumoto I, et al
    [Adenocarcinoma of an augmented bladder 49 years after enterocystoplasty : a case report].
    Hinyokika Kiyo. 2015;61:167-71.
    Abstract     Related articles   

  325. FUJIKAWA S, Iguchi R, Noguchi T, Sasaki M, et al
    [Cholesterol crystal embolization following urinary diversion: a case report].
    Hinyokika Kiyo. 2015;61:99-102.
    Abstract     Related articles   

  326. MONTIRONI R, Santoni M, Goteri G, Mazzucchelli R, et al
    Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.
    Hum Pathol. 2015 Mar 25. pii: S0046-8177(15)00088.
    Abstract     Related articles   

  327. ZENG T, Peng L, Chao H, Xi H, et al
    IRE1alpha-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells.
    Biochem Biophys Res Commun. 2015;460:530-6.
    Abstract     Related articles   

  328. KAWADA H, Kanematsu M, Goshima S, Kondo H, et al
    Multiphase contrast-enhanced magnetic resonance imaging features of Bacillus Calmette-Guerin-induced granulomatous prostatitis in five patients.
    Korean J Radiol. 2015;16:342-8.
    Abstract     Related articles   

  329. WEI S, Bing Z, Yao Y, Master SR, et al
    Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker.
    Acta Cytol. 2015;59:109-12.
    Abstract     Related articles   

  330. FOGAZZI GB, Pallotti F, Garigali G
    Atypical/malignant urothelial cells in routine urinary sediment: worth knowing and reporting.
    Clin Chim Acta. 2015;439:107-11.
    Abstract     Related articles   

  331. JUNQUEIRA-NETO S, Vieira FQ, Montezuma D, Costa NR, et al
    Phenotypic impact of deregulated expression of class I histone deacetylases in urothelial cell carcinoma of the bladder.
    Mol Carcinog. 2015;54:523-31.
    Abstract     Related articles   

  332. KAWAHARA T, Shareef HK, Aljarah AK, Ide H, et al
    ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Oncotarget. 2015.
    Abstract     Related articles   

  333. KIM BW, Ha Y, Lee JN, Kim HT, et al
    Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Urol J. 2015;12:2233-9.
    Abstract     Related articles   

  334. HAN B, Cui D, Jing Y, Hong Y, et al
    Erratum to: Estrogen receptor beta (ERbeta) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    World J Urol. 2015.
    Abstract     Related articles   

  335. FENNER A
    Bladder cancer: Patient-derived murine xenografts.
    Nat Rev Urol. 2015 Sep 1. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  336. DE PAOLI M, Perco P, Muhlberger I, Lukas A, et al
    Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic.
    Biomarkers. 2015;20:328-37.
    Abstract     Related articles   

  337. SCHMIDT J, Propping C, Siow WY, Lohse-Fischer A, et al
    Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
    J Cancer Res Clin Oncol. 2015.
    Abstract     Related articles   

  338. GARG M
    Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
    Cancer Metastasis Rev. 2015.
    Abstract     Related articles   

  339. BAUMANN BC, Noa K, Wileyto EP, Bekelman JE, et al
    Adjuvant radiation therapy for bladder cancer: A dosimetric comparison of techniques.
    Med Dosim. 2015 Aug 28. pii: S0958-3947(15)00068.
    Abstract     Related articles   

  340. PTASZYNSKA A, Cohen SM, Messing EM, Reilly TP, et al
    Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'.
    Diabetes Ther. 2015.
    Abstract     Related articles   

  341. ZHENG Y, Ishiguro H, Ide H, Inoue S, et al
    Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Mol Endocrinol. 2015 Aug 31:me20151128.
    Abstract     Related articles   

  342. COLE AP, Dalela D, Hanske J, Mullane SA, et al
    Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010.
    Urol Oncol. 2015 Aug 25. pii: S1078-1439(15)00358.
    Abstract     Related articles   

  343. MISHRA K, Behari A, Kapoor VK, Khan MS, et al
    Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:5647-54.
    Abstract     Related articles   

  344. TAN J, Qiu K, Li M, Liang Y, et al
    Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
    FEBS Lett. 2015 Aug 28. pii: S0014-5793(15)00720.
    Abstract     Related articles   

  345. AKBARI M, Naghibzadeh-Tahami A, Khanjani N, Baneshi MR, et al
    Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.
    Arch Iran Med. 2015;18:567-71.
    Abstract     Related articles   

  346. PATAFIO FM, Robert Siemens D, Wei X, Booth CM, et al
    Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  347. GOTTO GT, Shea-Budgell MA, Rose MS, Ruether JD, et al
    Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  348. CHENG Y, Deng X, Yang X, Li P, et al
    Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Onco Targets Ther. 2015;8:2089-96.
    Abstract     Related articles   

  349. REN L, Yang X, Zhao L, Zhang H, et al
    Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.
    Integr Cancer Ther. 2015 Aug 27. pii: 1534735415596569.
    Abstract     Related articles   

  350. SHOSTKA KG, Pavlenko AN, Fedchenko AV, Fokina AV, et al
    Vopr Onkol. 2015;61:448-51.
    Abstract     Related articles   

  351. PASQUIER D, Barney B, Sundar S, Poortmans P, et al
    Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
    Int J Radiat Oncol Biol Phys. 2015;92:904-10.
    Abstract     Related articles   

  352. GEAVLETE B, Bulai C, Ene C, Checherita I, et al
    The Influence of NBI Vision Over the First Follow-up Cystoscopy Outcomes in Newly Diagnosed NMIBC Patients.
    Chirurgia (Bucur). 2015;110:157-60.
    Abstract     Related articles   

  353. SHARMA P, Kini H, Pai RR, Sahu KK, et al
    Study of the reproducibility of the 2004 World Health Organization classification of urothelial neoplasms.
    Indian J Pathol Microbiol. 2015;58:59-61.
    Abstract     Related articles   

  354. CHATTERJEE D, Das A, Radotra BD
    Invasive micropapillary carcinoma of urinary bladder: a clinicopathological study.
    Indian J Pathol Microbiol. 2015;58:2-6.
    Abstract     Related articles   

  355. YU B, Zhou J, Cai H, Xu T, et al
    Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.
    BMC Urol. 2015;15:3.
    Abstract     Related articles   

  356. RALEIGH DR, Hsu IC, Braunstein S, Chang AJ, et al
    Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy.
    Brachytherapy. 2015;14:185-8.
    Abstract     Related articles   

  357. WAKUI S, Mutou T, Takahashi H, Ikegami M, et al
    Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    J Appl Toxicol. 2015;35:181-90.
    Abstract     Related articles   

  358. LIN Z, Shengnan L, Fei W, Yingli S, et al
    Dimethylarsinic acid (DMA(V) ) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder.
    J Appl Toxicol. 2015;35:133-41.
    Abstract     Related articles   

  359. DHULL VS, Karunanithi S, Arora S, Jain TK, et al
    Diuretic 68Ga DOTANOC PET/CT in Imaging of Bladder Paraganglioma.
    Clin Nucl Med. 2014.
    Abstract     Related articles   

  360. ATTALLAH AM, El-Far M, Abdallah SO, El-Waseef AM, et al
    Combined use of epithelial membrane antigen and nuclear matrix protein 52 as sensitive biomarkers for detection of bladder cancer.
    Int J Biol Markers. 2015 Aug 26:0. doi: 10.5301/jbm.5000164.
    Abstract     Related articles   

  361. GRUBMUELLER B, Roupret M, Briganti A, Shariat SF, et al
    The use of biomarkers for bladder cancer diagnosis and surveillance.
    Mini Rev Med Chem. 2015.
    Abstract     Related articles   

  362. SPRADLING K, Youssef RF
    Controversies Related to Diabetes and Risk of Bladder Cancer.
    Mini Rev Med Chem. 2015.
    Abstract     Related articles   

  363. MCBETH L, Grabnar M, Selman S, Hinds TD Jr, et al
    Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.
    Int J Endocrinol. 2015;2015:384860.
    Abstract     Related articles   

  364. KOSTAKOPOULOS N, Protogerou V, Skolarikos A, Varkarakis I, et al
    VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases.
    Ann Ital Chir. 2015;86:362-7.
    Abstract     Related articles   

  365. SHIN DH, Dier U, Melendez JA, Hempel N, et al
    Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells.
    Biochim Biophys Acta. 2015 Sep 5. pii: S0925-4439(15)00265.
    Abstract     Related articles   

  366. FEUERSTEIN MA, Goenka A
    Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy.
    Curr Urol Rep. 2015;16:547.
    Abstract     Related articles   

  367. KUWADA M, Chihara Y, Luo Y, Li X, et al
    Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer.
    Cancer Lett. 2015 Sep 2. pii: S0304-3835(15)00559.
    Abstract     Related articles   

  368. SANGWATANAROJ S, Khovinthasate D, Pathomyok L, Santingamkun A, et al
    Bladder Paraganglioma.
    Am J Med Sci. 2015;350:63.
    Abstract     Related articles   

  369. GUIMARAES MD, Bitencourt AG, Lima EN, Marchiori E, et al
    18FDG PET/CT Findings in the Unusual Urachal Adenocarcinoma.
    Clin Nucl Med. 2014.
    Abstract     Related articles   

    Point/Counterpoint: Is Cystectomy Needed for Small-Cell Bladder Cancer? NO.
    Oncology (Williston Park). 2015;29.
    Abstract     Related articles   

  371. FASCO DR
    Point/Counterpoint: Is Cystectomy Needed for Small-Cell Bladder Cancer? YES.
    Oncology (Williston Park). 2015;29.
    Abstract     Related articles   

  372. JAHNSON S, Hosseini Aliabad A, Holmang S, Jancke G, et al
    Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
    Scand J Urol. 2015.
    Abstract     Related articles   

  373. MOSCHINI M, Karnes RJ, Suardi N, Bianchi M, et al
    Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer.
    Clin Genitourin Cancer. 2015 Aug 18. pii: S1558-7673(15)00199.
    Abstract     Related articles   

  374. WEI S, Fukuhara H, Kawada C, Kurabayashi A, et al
    Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.
    Pathobiology. 2015;82:224-232.
    Abstract     Related articles   

  375. SCARPATO KR, Morgans AK, Moses KA
    Optimal management of muscle-invasive bladder cancer - a review.
    Res Rep Urol. 2015;7:143-51.
    Abstract     Related articles   

  376. LI P, Zhang X, Deng X, Tao J, et al
    Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin.
    Int J Clin Exp Med. 2015;8:11167-73.
    Abstract     Related articles   

  377. CHENG Y, Yang X, Deng X, Zhang X, et al
    Metabolomics in bladder cancer: a systematic review.
    Int J Clin Exp Med. 2015;8:11052-63.
    Abstract     Related articles   

  378. ROUANNE M, Alhammadi A, Vilain D, Radulescu C, et al
    Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer.
    World J Surg Oncol. 2015;13:276.
    Abstract     Related articles   

  379. ZHANG Q, Zhuang J, Deng Y, Zhao X, et al
    GOLPH3 is a potential therapeutic target and a prognostic indicatior of poor survival in bladder cancer treated by cystectomy.
    Oncotarget. 2015.
    Abstract     Related articles   

  380. FIGUEROA JD, Koutros S, Colt JS, Kogevinas M, et al
    Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
    J Natl Cancer Inst. 2015;107.
    Abstract     Related articles   

  381. LI HJ, Li X, Pang H, Pan JJ, et al
    Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  382. TAN M, Gong H, Wang J, Tao L, et al
    SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
    Sci Rep. 2015;5:13996.
    Abstract     Related articles   

  383. MILOSEVIC R, Milovic N, Aleksic P, Lazic M, et al
    The clinical course of non-muscle invasive bladder cancer after transurethral resection of the tumor with or without subsequent intravesical application of bacillus Calmette-Guerin: The influence of patients gender and age.
    Vojnosanit Pregl. 2015;72:596-601.
    Abstract     Related articles   

  384. SALAMA A, Abdelmaksoud AM, Shawki A, Abdelbary A, et al
    Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Clin Genitourin Cancer. 2015 Aug 6. pii: S1558-7673(15)00180.
    Abstract     Related articles   

  385. HAHN NM, Knudsen BS, Daneshmand S, Koch MO, et al
    Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
    Urol Oncol. 2015 Sep 8. pii: S1078-1439(15)00402.
    Abstract     Related articles   

  386. DUMAS G, Rousseau B, Rodrigues MJ, Tlemsani C, et al
    Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy.
    Clin Genitourin Cancer. 2015 Aug 6. pii: S1558-7673(15)00186.
    Abstract     Related articles   

  387. FANTONY JJ, Inman BA
    It May Be Time to Abandon Urine Tests for Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1163-6.
    Abstract     Related articles   

  388. PAPADOPOULOS EI, Scorilas A
    Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.
    Clin Transl Sci. 2015 Sep 10. doi: 10.1111/cts.12323.
    Abstract     Related articles   

  389. DENG X, Yang X, Cheng Y, Liu X, et al
    GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
    Sci Rep. 2015;5:14000.
    Abstract     Related articles   

  390. CHAN ES, Yee CH, Chiu PK, Chan CK, et al
    Robot-assisted radical cystectomy using a side-docking technique.
    J Laparoendosc Adv Surg Tech A. 2015;25:207-11.
    Abstract     Related articles   

  391. NAKSHATRI H, Appaiah HN, Anjanappa M, Gilley D, et al
    NF-kappaB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Cell Death Dis. 2015;6:e1608.
    Abstract     Related articles   

  392. PYUN JH, Kim HK, Kim JY, Kim SB, et al
    Standardized analysis of complications after robot-assisted radical cystectomy: Korea University Hospital experience.
    Korean J Urol. 2015;56:48-55.
    Abstract     Related articles   

  393. MAKBOUL R, Refaiy AE, Badary FA, Abdelkawi IF, et al
    Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Korean J Urol. 2015;56:31-40.
    Abstract     Related articles   

  394. BUTI S, Ciccarese C, Zanoni D, Santoni M, et al
    Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
    Future Oncol. 2015;11:107-19.
    Abstract     Related articles   

  395. CHUNG KT
    Occurrence, uses, and carcinogenicity of arylamines.
    Front Biosci (Elite Ed). 2015;7:322-45.
    Abstract     Related articles   

  396. RICHTER E
    Biomonitoring of human exposure to arylamines.
    Front Biosci (Elite Ed). 2015;7:193-207.
    Abstract     Related articles   

  397. MCDONALD F, Waters R, Gulliford S, Hall E, et al
    Defining bowel dose volume constraints for bladder radiotherapy treatment planning.
    Clin Oncol (R Coll Radiol). 2015;27:22-9.
    Abstract     Related articles   

  398. VAL-BERNAL JF, Azueta A, Ballestero R, Fuentes J, et al
    Incidental bladder lipoma: a case report and review of the literature.
    Turk Patoloji Derg. 2015;31:64-7.
    Abstract     Related articles   

  399. DI MARTINO E, Kelly G, Roulson JA, Knowles MA, et al
    Alteration of cell-cell and cell-matrix adhesion in urothelial cells: an oncogenic mechanism for mutant FGFR3.
    Mol Cancer Res. 2015;13:138-48.
    Abstract     Related articles   

  400. MILLIS SZ, Bryant D, Basu G, Bender R, et al
    Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.
    Clin Genitourin Cancer. 2015;13:e37-49.
    Abstract     Related articles   

  401. MUNARI E, Chaux A, Maldonado L, Comperat E, et al
    Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection.
    Histopathology. 2015;66:262-9.
    Abstract     Related articles   

  402. ZHANG XR, Feng C, Zhu WD, Si JM, et al
    Two Micrometer Continuous-Wave Thulium Laser Treating Primary Non-Muscle-Invasive Bladder Cancer: Is It Feasible? A Randomized Prospective Study.
    Photomed Laser Surg. 2015.
    Abstract     Related articles   

  403. WILZ SW, Liu D, Liu C, Yang J, et al
    Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins.
    Am J Transl Res. 2015;7:1458-66.
    Abstract     Related articles   

  404. ZHAO X, Li J, Huang S, Wan X, et al
    MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.
    Am J Transl Res. 2015;7:1382-9.
    Abstract     Related articles   

  405. SCHMID SC, Thumer L, Schuster T, Horn T, et al
    Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.
    Infect Agent Cancer. 2015;10:31.
    Abstract     Related articles   

  406. LEE J, Jeon H, Yoo SM, Park J, et al
    The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  407. VAN KESSEL KE, Zuiverloon TC, Alberts AR, Boormans JL, et al
    Targeted therapies in bladder cancer: an overview of in vivo research.
    Nat Rev Urol. 2015 Sep 22. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  408. BJORNSSON O, Gudmundsson EO, Marteinsson VT, Jonsson E, et al
    Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study.
    Scand J Urol. 2015.
    Abstract     Related articles   

  409. JAIN M, Robinson BD, Shevchuk MM, Aggarwal A, et al
    Multiphoton microscopy: a potential intraoperative tool for the detection of carcinoma in situ in human bladder.
    Arch Pathol Lab Med. 2015;139:796-804.
    Abstract     Related articles   

  410. GUPTA S, Gupta K, Ravi R, Mehta V, et al
    Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.
    Indian J Endocrinol Metab. 2015;19:639-43.
    Abstract     Related articles   

  411. SHINOTSUKA M, Shirai S, Tokuda Y
    Deep Vein Thrombosis due to Metastatic Bladder Cancer.
    Intern Med. 2015;54:2527-8.
    Abstract     Related articles   

  412. YOSHIDA T, Kinoshita H, Yoshida K, Yanishi M, et al
    A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  413. CHEN SP, Kirsch S, Zlatev DV, Chang T, et al
    Optical Biopsy of Bladder Cancer Using Crowd-Sourced Assessment.
    JAMA Surg. 2015 Sep 30:1-3. doi: 10.1001/jamasurg.2015.3121.
    Abstract     Related articles   

  414. HO PL, Willis DL, Patil J, Xiao L, et al
    Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.
    Urol Oncol. 2015 Sep 25. pii: S1078-1439(15)00411.
    Abstract     Related articles   

  415. PISTAMALTZIAN N, Tzannis K, Pissanidou V, Peroukidis S, et al
    Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.
    Anticancer Drugs. 2015.
    Abstract     Related articles   

  416. SCHUBERT T, Todenhofer T, Mischinger J, Schwentner C, et al
    The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  417. LOKE YK, Mattishent K
    Bladder cancer: Pioglitazone-when is a prescription drug safe?
    Nat Rev Urol. 2015 Sep 29. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  418. TSUZUKI S, Miki J, Moritake J, Kimura S, et al
    Nihon Hinyokika Gakkai Zasshi. 2015;106:71-8.
    Abstract     Related articles   

  419. ZHAO C, Tang K, Yang H, Xia D, et al
    Bipolar versus Monopolar Transurethral Resection of Non-muscle Invasive Bladder CancerA Meta-analysis.
    J Endourol. 2015.
    Abstract     Related articles   

  420. HEGAZY R, Kamel M, Salem EA, Salem NA, et al
    The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin.
    Arab J Urol. 2015;13:225-30.
    Abstract     Related articles   

  421. KOUTROS S, Silverman DT, Alavanja MC, Andreotti G, et al
    Occupational exposure to pesticides and bladder cancer risk.
    Int J Epidemiol. 2015.
    Abstract     Related articles   

  422. WU K, Wang B, Chen Y, Zhou J, et al
    DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling.
    Cell Signal. 2015 Sep 25. pii: S0898-6568(15)00276.
    Abstract     Related articles   

  423. BAO L, Wang Y, Ma R, Ren X, et al
    Apoptosis-inducing effects of lentinan on the proliferation of human bladder cancer T24 cells.
    Pak J Pharm Sci. 2015;28:1595-600.
    Abstract     Related articles   

  424. WHALLEY D, Caine H, McCloud P, Guo L, et al
    Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
    Radiat Oncol. 2015;10:205.
    Abstract     Related articles   

  425. NAKASHIMA M, Matsui Y, Kobayashi T, Saito R, et al
    Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer.
    Cancer Biomark. 2015;15:357-64.
    Abstract     Related articles   

  426. VTORENKO VI, Trushkin RN, Lubennikov AE, Podkorytova OL, et al
    Urologiia. 2015;:126-9.
    Abstract     Related articles   

  427. YU G, Xu K, Xu S, Zhang X, et al
    [MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:935-40.
    Abstract     Related articles   

  428. LU XL, Shen YJ, Ye DW
    [Penile rehabilitation after radical pelvic surgery].
    Zhonghua Nan Ke Xue. 2015;21:463-6.
    Abstract     Related articles   

  429. CASTILLO JJ, Olszewski AJ, Kanan S, Meid K, et al
    Survival outcomes of secondary cancers in patients with Waldenstrom macroglobulinemia: An analysis of the SEER database.
    Am J Hematol. 2015;90:696-701.
    Abstract     Related articles   

  430. BOTELHO MC, Alves H, Barros A, Rinaldi G, et al
    The role of estrogens and estrogen receptor signaling pathways in cancer and infertility: the case of schistosomes.
    Trends Parasitol. 2015;31:246-50.
    Abstract     Related articles   

  431. CHAKIBA C, Cornelis F, Descat E, Gross-Goupil M, et al
    Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma.
    Eur J Radiol. 2015 Mar 6. pii: S0720-048X(15)00118.
    Abstract     Related articles   

  432. GABALLAH HH, Shafik NM, Wasfy RE, Abou Farha MO, et al
    Significance of suppressor of cytokine signaling-3 expression in bladder urothelial carcinoma in relation to proinflammatory cytokines and tumor histopathological grading.
    Asian Pac J Cancer Prev. 2015;16:307-14.
    Abstract     Related articles   

  433. RASHID ALI MR, Kannan KK
    Endobronchial glomus tumor.
    J Bronchology Interv Pulmonol. 2015;22:66-8.
    Abstract     Related articles   

  434. CALADO BN, Maron PE, Vedovato BC, Barrese TZ, et al
    Small cell carcinoma of the bladder.
    Einstein (Sao Paulo). 2015;13:114-6.
    Abstract     Related articles   

  435. HAN YJ, Ock SY, Kim EJ, Shin HS, et al
    Thunderclap-like headache triggered by micturition and angina as an initial manifestation of bladder pheochromocytoma. A case report.
    Sao Paulo Med J. 2015;133:154-9.
    Abstract     Related articles   

  436. CUMBERBATCH MG, Cox A, Teare D, Catto JW, et al
    Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.
    JAMA Oncol. 2015 Oct 8:1-9. doi: 10.1001/jamaoncol.2015.3209.
    Abstract     Related articles   

  437. WEIDERPASS E, Vainio H
    The Need for Further Preventive Measures for Occupational Bladder Cancer.
    JAMA Oncol. 2015 Oct 8:1-2. doi: 10.1001/jamaoncol.2015.3270.
    Abstract     Related articles   

  438. BUSATO JUNIOR WF, Almeida GL, Ribas CA, Ribas Filho JM, et al
    EORTC Risk Model to Predict Progression in Patients With Non-Muscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice?
    Clin Genitourin Cancer. 2015 Sep 25. pii: S1558-7673(15)00246.
    Abstract     Related articles   

  439. KWON T, Jeong IG, Lee C, You D, et al
    Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  440. ERTURHAN S, Sen H, Demirbag A, Bayrak O, et al
    Thermochemotherapy in adjuvant treatment of primary high risk non muscle invasive bladder cancers: Single center results.
    Arch Esp Urol. 2015;68:666-671.
    Abstract     Related articles   

  441. YEH HC, Huang CN, Li CC, Chang LL, et al
    Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  442. HARB-DE LA ROSA A, Acker M, Kumar RA, Manoharan M, et al
    Epigenetics application in the diagnosis and treatment of bladder cancer.
    Can J Urol. 2015;22:7947-51.
    Abstract     Related articles   

  443. GUNARATNE DA, Krieger LE, Maclean F, Vaux KJ, et al
    Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2015 Sep 3. pii: S1558-7673(15)00223.
    Abstract     Related articles   

  444. LEE MS, Lee J, Kim JH, Kim WT, et al
    Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  445. WU M, Chen J, Wang Y, Hu J, et al
    URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-kappaB signaling.
    Oncotarget. 2015.
    Abstract     Related articles   

  446. FENG YH, Shen KH, Huang KH, Tzeng WS, et al
    An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2015 Aug 29. pii: S1558-7673(15)00219.
    Abstract     Related articles   

  447. RAIS-BAHRAMI S, Pietryga JA, Nix JW
    Contemporary role of advanced imaging for bladder cancer staging.
    Urol Oncol. 2015 Sep 28. pii: S1078-1439(15)00441.
    Abstract     Related articles   

  448. LIN J, Liu Y, Zhan Y, Zhuang C, et al
    Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  449. CHEN L, Cui Z, Liu Y, Bai Y, et al
    MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Clin Lab. 2015;61:1101-8.
    Abstract     Related articles   

  450. TAKEUCHI M, Sasaguri K, Naiki T, Mitsumori A, et al
    MRI Findings of Inverted Urothelial Papilloma of the Bladder.
    AJR Am J Roentgenol. 2015;205:311-6.
    Abstract     Related articles   

  451. FONTANAROSA PB, Bauchner H, Golub RM
    Evaluating Research on the Safety of Medical Therapies: The Responsibility of Journals to the Health of the Public.
    JAMA. 2015;314:235-6.
    Abstract     Related articles   

  452. SHARFSTEIN JM, Kesselheim AS
    The Safety of Prescription Drugs.
    JAMA. 2015;314:233-4.
    Abstract     Related articles   

  453. CASTIGLIONI S, Cazzaniga A, Perrotta C, Maier JA, et al
    Silver nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells.
    Toxicol Lett. 2015;237:237-43.
    Abstract     Related articles   

  454. CALATRONI M, Buzio C, Vaglio A
    The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis.
    Rheumatology (Oxford). 2015;54:1339-41.
    Abstract     Related articles   

  455. ZHANG GW, Qin GF, Han B, Li CX, et al
    Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma.
    Carbohydr Polym. 2015;118:30-5.
    Abstract     Related articles   

  456. MATTES MD, Kan CC, Dalbagni G, Zelefsky MJ, et al
    External beam radiation therapy for small cell carcinoma of the urinary bladder.
    Pract Radiat Oncol. 2015;5:e17-22.
    Abstract     Related articles   

  457. FAURSCHOU M, Mellemkjaer L, Voss A, Keller KK, et al
    Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Rheumatology (Oxford). 2015;54:1345-50.
    Abstract     Related articles   

  458. SUN X, Du P, Yuan W, Du Z, et al
    Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.
    Cell Death Dis. 2015;6:e1907.
    Abstract     Related articles   

  459. DEMBOWSKI J, Hackemer P, Winkler A, Otlewska A, et al
    Prostate and Bladder Cancer Coexistence in Patients Undergoing Radical Cystoprostatectomy.
    Adv Clin Exp Med. 2015;24:657-662.
    Abstract     Related articles   

  460. CERBONE L, Sternberg CN, Sengelov L, Agerbaek M, et al
    Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.
    Oncology. 2015.
    Abstract     Related articles   

  461. LERUT E, Van Poppel H, Joniau S, Gruselle O, et al
    Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
    Int J Clin Exp Pathol. 2015;8:9522-32.
    Abstract     Related articles   

  462. SUER E, Hamidi N, Gokce MI, Gulpinar O, et al
    Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    World J Urol. 2015.
    Abstract     Related articles   

  463. LIU PF, Cao YW, Zhang SD, Zhao Y, et al
    A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Oncotarget. 2015 Oct 10. doi: 10.18632/oncotarget.6070.
    Abstract     Related articles   

  464. CAI Q, Wu Y, Guo Z, Gong R, et al
    Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Oncotarget. 2015.
    Abstract     Related articles   

  465. JIANG L, Wen J, Luo W
    Rhoassociated kinase inhibitor, Y27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.
    Mol Med Rep. 2015 Sep 30. doi: 10.3892/mmr.2015.4404.
    Abstract     Related articles   

  466. DENG S, Wang W, Li X, Zhang P, et al
    Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer.
    World J Surg Oncol. 2015;13:297.
    Abstract     Related articles   

  467. QIU M, Chen L, Tan G, Ke L, et al
    A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.
    Sci Rep. 2015;5:15104.
    Abstract     Related articles   

  468. MARTINEZ-FERNANDEZ M, Feber A, Duenas M, Segovia C, et al
    Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer.
    Clin Epigenetics. 2015;7:109.
    Abstract     Related articles   

  469. ARNOLD SA, Loomans HA, Ketova T, Andl CD, et al
    Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
    Clin Exp Metastasis. 2015.
    Abstract     Related articles   

  470. DENG Y, Yi L, Lin X, Lin L, et al
    A non-invasive genomic diagnostic method for bladder cancer using size-based filtration and microchip electrophoresis.
    Talanta. 2015;144:136-44.
    Abstract     Related articles   

  471. LIU C, Ren H, Li J, Li X, et al
    Predictors for quality of life of bladder cancer patients with ileal conduit: A cross-sectional survey.
    Eur J Oncol Nurs. 2015 Oct 6. pii: S1462-3889(15)30031.
    Abstract     Related articles   

  472. FERREIRA-TEIXEIRA M, Parada B, Rodrigues-Santos P, Alves V, et al
    Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
    Oncotarget. 2015.
    Abstract     Related articles   

  473. NIINO M, Matsuda T
    Morphological distribution of bladder cancer from Cancer Incidence in Five Continents Vol. X.
    Jpn J Clin Oncol. 2015;45:999.
    Abstract     Related articles   

  474. ZHU H, Li X, Song Y, Zhang P, et al
    Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway.
    Biochem Biophys Res Commun. 2015 Oct 7. pii: S0006-291X(15)30702.
    Abstract     Related articles   

  475. KAUFMANN S, Amend B, Kruck S, Gakis G, et al
    [Imaging findings in BCGitis--Bacillus-Calmette-Guerin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
    Rofo. 2015;187:623-7.
    Abstract     Related articles   

  476. STOJADINOVIC MM, Prelevic RI
    External validation of existing nomograms predicting lymph node metastases in cystectomized patients.
    Int J Clin Oncol. 2015;20:164-70.
    Abstract     Related articles   

  477. ZEPEDA CM, Coffey KH
    Schistosoma haematobium Infection That Mimics Bladder Cancer in a 66-Year-Old Ethnic Egyptian Man.
    Lab Med. 2015;46:338-42.
    Abstract     Related articles   

  478. LUO HB, Li B, Yuan WG, Xu CR, et al
    Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    J Huazhong Univ Sci Technolog Med Sci. 2015;35:730-5.
    Abstract     Related articles   

  479. TIAN YF, Zhou H, Yu G, Wang J, et al
    Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.
    J Huazhong Univ Sci Technolog Med Sci. 2015;35:646-55.
    Abstract     Related articles   

  480. REGLI S, Chen J, Messner M, Elovitz MS, et al
    Estimating Potential Increased Bladder Cancer Risk Due to Increased Bromide Concentrations in Sources of Disinfected Drinking Waters.
    Environ Sci Technol. 2015.
    Abstract     Related articles   

  481. GONG Z, Xu H, Su Y, Wu W, et al
    Establishment of a Novel Bladder Cancer Xenograft Model in Humanized Immunodeficient Mice.
    Cell Physiol Biochem. 2015;37:1355-1368.
    Abstract     Related articles   

  482. KATES M, Sopko NA, Matsui H, Drake CG, et al
    Immune checkpoint inhibitors: a new frontier in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  483. SMITH ZL, Soloway MS
    Expectant Management of Low-Risk Bladder Cancer.
    Curr Urol Rep. 2015;16:82.
    Abstract     Related articles   

  484. CHEN X, Gu P, Li K, Xie W, et al
    Gene expression profiling of WDR5 regulated genes in bladder cancer.
    Genom Data. 2015;5:27-9.
    Abstract     Related articles   

  485. SERRETTA V, Scalici Gesolfo C
    Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer.
    Urologia. 2015;0:0.
    Abstract     Related articles   

  486. NASELLI A, Puppo P
    Narrow band imaging and bladder cancer: when and how.
    Urologia. 2015;0:0.
    Abstract     Related articles   

  487. BOADA LD, Henriquez-Hernandez LA, Zumbado M, Almeida-Gonzalez M, et al
    Organochlorine pesticides exposure and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain).
    J Agromedicine. 2015.
    Abstract     Related articles   

  488. LERNER SP
    Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2015;1:94-95.
    Abstract     Related articles   

  489. JAISWAL MK, Pradhan L, Vasavada S, De M, et al
    Magneto-thermally responsive hydrogels for bladder cancer treatment: Therapeutic efficacy and in vivo biodistribution.
    Colloids Surf B Biointerfaces. 2015;136:625-633.
    Abstract     Related articles   

  490. ZHAO Y, Wang D, Xu T, Liu P, et al
    Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment.
    Oncotarget. 2015 Oct 13. doi: 10.18632/oncotarget.5538.
    Abstract     Related articles   

  491. ZHANG X, Liu D, Hayashida Y, Okazoe H, et al
    G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.
    Int J Mol Sci. 2015;16:24319-31.
    Abstract     Related articles   

  492. ABBOSH PH, McConkey DJ, Plimack ER
    Targeting Signaling Transduction Pathways in Bladder Cancer.
    Curr Oncol Rep. 2015;17:58.
    Abstract     Related articles   

  493. RASSHUPKINAL EV, Teodorovich OV, Kochiev DG, Andreeva JJ, et al
    Urologiia. 2015;:55-9.
    Abstract     Related articles   

  494. UMBAS R, Safriadi F, Mochtar CA, Djatisoesanto W, et al
    Urologic cancer in Indonesia.
    Jpn J Clin Oncol. 2015;45:708-12.
    Abstract     Related articles   

  495. GUPTA M, Su LM
    Current and evolving uses of optical coherence tomography in the genitourinary tract.
    Curr Urol Rep. 2015;16:15.
    Abstract     Related articles   

  496. KATES M, Singh A, Matsui H, Steinberg GD, et al
    Tissue-engineered urinary conduits.
    Curr Urol Rep. 2015;16:8.
    Abstract     Related articles   

  497. KALRA S, Manikandan R, Dorairajan LN, Badhe B, et al
    Synchronously detected secondary signet ring cell urinary bladder malignancy from the stomach masquerading as genitourinary tuberculosis.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  498. HO CH, Sung KC, Lim SW, Liao CH, et al
    Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury.
    Medicine (Baltimore). 2015;94:e1736.
    Abstract     Related articles   

  499. LATIFOVIC L, Villeneuve PJ, Parent ME, Johnson KC, et al
    Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men.
    Cancer Med. 2015 Oct 28. doi: 10.1002.
    Abstract     Related articles   

  500. AY SENYIGIT Z, Karavana SY, Ilem-Ozdemir D, Caliskan C, et al
    Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
    Int J Nanomedicine. 2015;10:6493-507.
    Abstract     Related articles   

  501. ISMAIL MF, El Boghdady NA, Shabayek MI, Awida HA, et al
    Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.
    Tumour Biol. 2015.
    Abstract     Related articles   

  502. KALINSKI P, Gingrich JR
    Toward improved effectiveness of bladder cancer immunotherapy.
    Immunotherapy. 2015.
    Abstract     Related articles   

  503. WISE J
    Urinary biomarkers are unreliable for diagnosing bladder cancer, study finds.
    BMJ. 2015;351:h5652.
    Abstract     Related articles   

  504. ZHU X, Qiao Y, Liu W, Wang W, et al
    CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Tumour Biol. 2015.
    Abstract     Related articles   

  505. CHOU R, Gore JL, Buckley D, Fu R, et al
    Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2015 Oct 27. doi: 10.7326/M15-0997.
    Abstract     Related articles   

  506. JOZWICKI W, Brozyna AA, Siekiera J, Slominski AT, et al
    Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.
    Int J Mol Sci. 2015;16:24369-86.
    Abstract     Related articles   

  507. AYKAN S, Yuruk E, Tuken M, Temiz MZ, et al
    Rare but Lethal Disease of Childhood: Metastatic, Muscle Invasive Bladder Cancer.
    Pediatr Rep. 2015;7:5928.
    Abstract     Related articles   

  508. VANDERWALDE NA, Chi MT, Hurria A, Galsky MD, et al
    Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.
    World J Urol. 2015.
    Abstract     Related articles   

  509. FERRO M, De Cobelli O, Buonerba C, Di Lorenzo G, et al
    Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
    Medicine (Baltimore). 2015;94:e1861.
    Abstract     Related articles   

  510. YANG J, Yuan D, Li J, Zheng S, et al
    miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
    Tumour Biol. 2015.
    Abstract     Related articles   

  511. CHEN Y, Zhu G, Wu K, Gao Y, et al
    FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.
    Tumour Biol. 2015.
    Abstract     Related articles   

  512. IMAJO Y, Komasawa N, Ishio J, Miyazakl Y, et al
    [A Case of Severe Bradycardia Associated with Bladder Perforation during Spinal Anesthesia].
    Masui. 2015;64:552-4.
    Abstract     Related articles   

  513. VENTOSA-FERNANDEZ G, Milisenda JC, Pereda D, Mestres CA, et al
    Infected False Aneurysm of the Aortic Arch After Endoscopic Transurethral Instillation of Bacillus Calmette-Guerin.
    Ann Thorac Surg. 2015;100:717-20.
    Abstract     Related articles   

  514. CHANG IW, Liang PI, Li CC, Wu WJ, et al
    HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
    Tumour Biol. 2015;36:5441-50.
    Abstract     Related articles   

  515. ZHANG Z, Zhang G, Kong C, Bi J, et al
    EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma.
    Tumour Biol. 2015;36:5071-9.
    Abstract     Related articles   

  516. XIE D, Shang C, Zhang H, Guo Y, et al
    Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma.
    Med Sci Monit. 2015;21:225-30.
    Abstract     Related articles   

  517. BHATTACHARYA A, Klaene JJ, Li Y, Paonessa JD, et al
    The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage.
    Oncotarget. 2015;6:836-45.
    Abstract     Related articles   

  518. LI T, Huang H, Liao D, Ling H, et al
    Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Mol Genet Genomics. 2015;290:1235-45.
    Abstract     Related articles   

  519. QUIST EE, Javadzadeh BM, Johannesen E, Johansson SL, et al
    Malignant paraganglioma of the bladder: a case report and review of the literature.
    Pathol Res Pract. 2015;211:183-8.
    Abstract     Related articles   

  520. ROUMEGUERE T, Broeders N, Jayaswal A, Rorive S, et al
    Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.
    Transpl Int. 2014 Nov 6. doi: 10.1111/tri.12484.
    Abstract     Related articles   

  521. ALBANY C, Sonpavde G
    Docetaxel for the treatment of bladder cancer.
    Expert Opin Investig Drugs. 2015.
    Abstract     Related articles   

  522. BARTLEY K, DeBusk K, Duff S
    Health-Related Quality Of Life In Bladder Cancer: A Systematic Literature Review.
    Value Health. 2015;18:A474-5.
    Abstract     Related articles   

  523. CLARK M, Harris NI, Martin S, Bartley K, et al
    The Impact Of Non-Muscle Invasive Bladder Cancer: Qualitative Research With Patients.
    Value Health. 2015;18:A471.
    Abstract     Related articles   

  524. JABLONOWSKI Z, Konecki T, Ziobro M, Haldas M, et al
    Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland
    Value Health. 2015;18:A360.
    Abstract     Related articles   

  525. DANSK V, Malmstrom P, Blackberg M, Malmenas M, et al
    Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer: Cost-Consequences During Outpatient Surveillance In Sweden.
    Value Health. 2015;18:A354.
    Abstract     Related articles   

  526. ECKE TH
    Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer.
    Adv Exp Med Biol. 2015;867:293-316.
    Abstract     Related articles   

    JAMA PATIENT PAGE. Bladder Cancer.
    JAMA. 2015;314:1886.
    Abstract     Related articles   

  528. JIN D, Chen H, Cao M, Yang G, et al
    SERS measurement of the bladder cancer cells with the nanoparticles.
    Pak J Pharm Sci. 2015;28.
    Abstract     Related articles   

  529. CASTILLO-MARTIN M, Collazo Lorduy A, Gladoun N, Hyun G, et al
    H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    J Pediatr Urol. 2015 Oct 22. pii: S1477-5131(15)00368.
    Abstract     Related articles   

  530. ZHANG ZW, Xiao J, Luo W, Wang BH, et al
    Caffeine Suppresses Apoptosis of Bladder Cancer RT4 Cells in Response to Ionizing Radiation by Inhibiting Ataxia Telangiectasia Mutated-Chk2-p53 Axis.
    Chin Med J (Engl). 2015;128:2938-45.
    Abstract     Related articles   

  531. DI LORENZO G, Federico P, De Placido S, Buonerba C, et al
    Increased risk of bladder cancer in critical areas at high pressure of pollution of the Campania region in Italy: A systematic review.
    Crit Rev Oncol Hematol. 2015 Jul 20. pii: S1040-8428(15)30004.
    Abstract     Related articles   

  532. VON SCHOEN-ANGERER T, Wilkens J, Kienle GS, Kiene H, et al
    High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
    Perm J. 2015;19:76-83.
    Abstract     Related articles   

  533. LIN C, Lin W, Yeh S, Li L, et al
    Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.
    Oncotarget. 2015 Oct 16. doi: 10.18632/oncotarget.5638.
    Abstract     Related articles   

  534. ZHUANG C, Li J, Liu Y, Chen M, et al
    Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
    Oncotarget. 2015 Oct 15. doi: 10.18632/oncotarget.5880.
    Abstract     Related articles   

  535. MARTINEZ-FERNANDEZ M, Duenas M, Feber A, Segovia C, et al
    A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Oncotarget. 2015 Oct 17. doi: 10.18632/oncotarget.5546.
    Abstract     Related articles   

  536. PAKZAD R, Mohammadian-Hafshejani A, Mohammadian M, Pakzad I, et al
    Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia.
    Asian Pac J Cancer Prev. 2015;16:7365-74.
    Abstract     Related articles   

  537. ZENG Y, Jiang HY, Wei L, Xu WD, et al
    Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
    Asian Pac J Cancer Prev. 2015;16:7249-54.
    Abstract     Related articles   

  538. TAN J, Sun C, Xu K, Wang C, et al
    Immobilization of ALA-Zn Coordination Polymer Pro-photosensitizers on Magnetite Colloidal Supraparticles for Target Photodynamic Therapy of Bladder Cancer.
    Small. 2015 Oct 30. doi: 10.1002/smll.201502131.
    Abstract     Related articles   

  539. ZOLOTAREVA EV, Andreeva YY, Frank GA
    [Lymphoepithelioma-like tumors: A review of literature and a clinical case of bladder carcinoma].
    Arkh Patol. 2015;77:55-62.
    Abstract     Related articles   

  540. JAYARAM A, Zafeiriou Z, de Bono JS
    Cabozantinib-Getting Under the Skin of Cutaneous Toxicity.
    JAMA Oncol. 2015;1:535-6.
    Abstract     Related articles   

  541. GIERTH M, Mayr R, Aziz A, Krieger S, et al
    Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.
    J Cancer Res Clin Oncol. 2015;141:1819-26.
    Abstract     Related articles   

  542. BALCI U, Dogantekin E, Ozer K, Gorgel SN, et al
    Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience.
    Int J Surg. 2015;13:148-51.
    Abstract     Related articles   

  543. HUAN T, Li L
    Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
    Anal Chem. 2015;87:1306-13.
    Abstract     Related articles   

    A novel biomarker for diagnosis of bladder cancer.
    Nihon Yakurigaku Zasshi. 2015;146:248-51.
    Abstract     Related articles   

  545. RAO Q, Chen Y, Yeh CR, Jie D, et al
    Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERbeta/CCL2/CCR2 EMT/MMP9 signals.
    Oncotarget. 2015 Nov 5. doi: 10.18632/oncotarget.5467.
    Abstract     Related articles   

  546. CAVANAUGH A, Juengst B, Sheridan K, Danella JF, et al
    Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
    Oncotarget. 2015 Nov 4. doi: 10.18632/oncotarget.5496.
    Abstract     Related articles   

  547. HIGASHIOKA K, Miyake N, Nishida R, Chong Y, et al
    [Bilateral Granulomatous Renal Masses after Intravesical BCG Therapy for Non-muscle-invasive Bladder Cancer and Carcinoma in Situ of the Upper Urinary Tract: A Case Study].
    Kansenshogaku Zasshi. 2015;89:481-4.
    Abstract     Related articles   

  548. STONE L
    Bladder cancer: In the driving seat - AGL loss drives tumour growth.
    Nat Rev Urol. 2015 Nov 10. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  549. CHEN T, Xie W, Xie L, Sun Y, et al
    Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Biochem Biophys Res Commun. 2015 Nov 6. pii: S0006-291X(15)30881.
    Abstract     Related articles   

  550. LI M, Yu X, Cheng L, Huang Y, et al
    Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer.
    Int J Clin Exp Med. 2015;8:13259-66.
    Abstract     Related articles   

  551. ZENG J, Liao Y, Zhou J, Yang G, et al
    Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells.
    Int J Clin Exp Med. 2015;8:12792-800.
    Abstract     Related articles   

  552. XU XD, Shao SX, Cao YW, Yang XC, et al
    The study of energy metabolism in bladder cancer cells in co-culture conditions using a microfluidic chip.
    Int J Clin Exp Med. 2015;8:12327-36.
    Abstract     Related articles   

  553. CORREA AF, Theisen K, Ferroni M, Maranchie JK, et al
    The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer.
    Adv Urol. 2015;2015:656918.
    Abstract     Related articles   

  554. APPEL JH, Ren H, Sin ML, Liao JC, et al
    Rapid bladder cancer cell detection from clinical urine samples using an ultra-thin silicone membrane.
    Analyst. 2015.
    Abstract     Related articles   

  555. DEMIRER Z, Uslu AU
    Predictive value of neutrophil-lymphocyte ratio in non-muscle-invasive bladder cancer.
    Urol Oncol. 2015 Nov 5. pii: S1078-1439(15)00449.
    Abstract     Related articles   

  556. ZHANG Z, Zhang G, Kong C, Gong D, et al
    PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway.
    Mol Med Rep. 2015 Nov 6. doi: 10.3892/mmr.2015.4528.
    Abstract     Related articles   

  557. LANTTO J, Isokangas OP, Saily M
    [Peripheral ischemia and heart failure as complications of neoadjuvant therapy of bladder cancer].
    Duodecim. 2015;131:1605-7.
    Abstract     Related articles   

  558. ZHANG S, Li J, Zhou G, Mu D, et al
    Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  559. MURTHY V, Masodkar R, Kalyani N, Mahantshetty U, et al
    Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2015 Sep 16. pii: S0360-3016(15)03321.
    Abstract     Related articles   

  560. GAO Y, Wu K, Chen Y, Zhou J, et al
    Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.
    Oncotarget. 2015 Oct 27. doi: 10.18632/oncotarget.6101.
    Abstract     Related articles   

  561. XUE M, Pang H, Li X, Li H, et al
    Long noncoding RNA UCA1 promotes bladder cancer cell migration and invasion via hsa-miR-145/ ZEB1/2 /FSCN1 pathway.
    Cancer Sci. 2015 Nov 6. doi: 10.1111/cas.12844.
    Abstract     Related articles   

  562. SHELLEY M, Court JB, Kynaston HG, Wilt TJ, et al
    WITHDRAWN: Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Cochrane Database Syst Rev. 2015;11:CD003231.
    Abstract     Related articles   

  563. BURNIER A, Shimizu Y, Dai Y, Nakashima M, et al
    CXCL1 is elevated in the urine of bladder cancer patients.
    Springerplus. 2015;4:610.
    Abstract     Related articles   

  564. WETTSTEIN MS, Buser L, Hermanns T, Roudnicky F, et al
    CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.
    Dis Markers. 2015;2015:785461.
    Abstract     Related articles   

  565. WANG QY, Zhao Y, Zhang R
    The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.
    Minerva Med. 2015.
    Abstract     Related articles   

  566. ZHAN Y, Liu Y, Lin J, Fu X, et al
    Synthetic Tet-inducible artificial microRNAs targeting beta-catenin or HIF-1alpha inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
    Sci Rep. 2015;5:16177.
    Abstract     Related articles   

  567. APOZNANSKI W, Rysiakiewicz J, Polok M, Rysiakiewicz K, et al
    Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
    Adv Clin Exp Med. 2015;24:505-9.
    Abstract     Related articles   

  568. KOO KC, Lee KS, Chung BH
    Urologic cancers in Korea.
    Jpn J Clin Oncol. 2015;45:805-11.
    Abstract     Related articles   

  569. ICHIOKA D, Miyazaki J, Inoue T, Kageyama S, et al
    Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes.
    Jpn J Clin Oncol. 2015;45:867-73.
    Abstract     Related articles   

  570. SHATAGOPAM K, Kaimakliotis HZ, Cheng L, Koch MO, et al
    Genitourinary small cell malignancies: prostate and bladder.
    Future Oncol. 2015;11:479-88.
    Abstract     Related articles   

  571. MARSH GM, Zimmerman SD
    Mortality among chemical plant workers exposed to acrylonitrile: 2011 follow-up.
    J Occup Environ Med. 2015;57:134-45.
    Abstract     Related articles   

  572. GASPERI V, Evangelista D, Oddi S, Florenzano F, et al
    Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors.
    Life Sci. 2015;138:41-51.
    Abstract     Related articles   

  573. YAMAMOTO T, Takahashi S, Ichihara K, Hiyama Y, et al
    How do we understand the disagreement in the frequency of surgical site infection between the CDC and Clavien-Dindo classifications?
    J Infect Chemother. 2015;21:130-3.
    Abstract     Related articles   

  574. LEVI F, Randimbison L, Rafael BM, Manuela MC, et al
    Second primary cancers in the Vaud and Neuchatel Cancer Registries.
    Eur J Cancer Prev. 2015;24:150-4.
    Abstract     Related articles   

  575. TSAI SC, Ou YC, Cheng CL, Li JR, et al
    Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
    Nuklearmedizin. 2014;54.
    Abstract     Related articles   

  576. SALVATORI R, Dackiw AP, Bishop J, Fishman EK, et al
    Bladder pheochromocytoma.
    Endocrine. 2015;48:349-50.
    Abstract     Related articles   

  577. KAGOTANI A, Ishida M, Yoshida K, Iwai M, et al
    High-grade urothelial carcinoma of the bladder with rhabdoid features: cytological and histological report of two cases.
    Cytopathology. 2015;26:54-6.
    Abstract     Related articles   

  578. WU Z, Liu K, Wang Y, Xu Z, et al
    Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.
    Cancer Cell Int. 2015;15:107.
    Abstract     Related articles   

  579. MARTINEZ-FERNANDEZ M, Rubio C, Segovia C, Lopez-Calderon FF, et al
    EZH2 in Bladder Cancer, a Promising Therapeutic Target.
    Int J Mol Sci. 2015;16:27107-27132.
    Abstract     Related articles   

  580. JOSEPH N, Dovedi SJ, Thompson C, Lyons J, et al
    Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.
    Ann Oncol. 2015.
    Abstract     Related articles   

  581. MADKA V, Mohammed A, Li Q, Zhang Y, et al
    Targeting mTOR and p53 signaling inhibits muscle invasive bladder cancer in vivo.
    Cancer Prev Res (Phila). 2015 Nov 17. pii: canprevres.0199.2015.
    Abstract     Related articles   

  582. TUOMIKOSKI L, Valli A, Tenhunen M, Muren L, et al
    A comparison between two clinically applied plan library strategies in adaptive radiotherapy of bladder cancer.
    Radiother Oncol. 2015 Nov 11. pii: S0167-8140(15)00554.
    Abstract     Related articles   

  583. ARMSTRONG DA, Green BB, Seigne JD, Schned AR, et al
    MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer.
    Mol Cancer. 2015;14:194.
    Abstract     Related articles   

  584. RANZI AD, da Silva JN, Graziottin TM, Annels N, et al
    Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer.
    Appl Immunohistochem Mol Morphol. 2015.
    Abstract     Related articles   

  585. ZHU YT, Pang SY, Lei CY, Luo Y, et al
    Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.
    Stem Cell Res Ther. 2015;6:224.
    Abstract     Related articles   

  586. SHARMA P, Zargar-Shoshtari K, Sexton WJ
    Valrubicin in refractory non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2015.
    Abstract     Related articles   

  587. OZER K, Horsanali MO, Gorgel SN, Ozbek E, et al
    Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer.
    Cent European J Urol. 2015;68:284-8.
    Abstract     Related articles   

  588. HONG Y, Esuvaranathan K, Pasikanti KK, Yong Chan EC, et al
    Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?
    Bioanalysis. 2015.
    Abstract     Related articles   

  589. BEOTHE T, Zubakov D, Kovacs G
    Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder.
    Cancer Genet. 2015;208:434-40.
    Abstract     Related articles   

  590. VIRSEDA-RODRIGUEZ AJ, Padilla-Fernandez B, Lopez-Parra M, Santos-Antunes MT, et al
    Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection.
    Arch Ital Urol Androl. 2015;87:136-40.
    Abstract     Related articles   

  591. YUKSEL OH, Verit A, Urkmez A
    What is the correct staging and treatment strategy for locally advanced prostate cancer extending to the bladder?
    Arch Ital Urol Androl. 2015;87:130-5.
    Abstract     Related articles   

  592. GUGLIERI-LOPEZ B, Perez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, et al
    Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.
    Anticancer Drugs. 2015;26:860-5.
    Abstract     Related articles   

  593. PAQUET ER, Hovington H, Brisson H, Lacombe C, et al
    Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis.
    Biomark Med. 2015;9:187-97.
    Abstract     Related articles   

  594. HUPE MC, Kramer MW, Merseburger AS
    Preoperative and modifiable factors to lower postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:19.
    Abstract     Related articles   

  595. SIM A, Todenhofer T, Mischinger J, Halalsheh O, et al
    Y pouch neobladder-a simplified method of intracorporeal neobladder after robotic cystectomy.
    J Endourol. 2015;29:387-9.
    Abstract     Related articles   

  596. NOUR HH, Gobashy SE, Kamal AM, Elbaz AG, et al
    Low-dose bacille Calmette-Guerin for non-muscle-invasive bladder cancer: Results of a prospective study.
    Arab J Urol. 2015;13:238-243.
    Abstract     Related articles   

  597. KANDEEL W, Abdelal A, Elmohamady BN, Sebaey A, et al
    A comparative study between full-dose and half-dose intravesical immune bacille Calmette-Guerin injection in the management of superficial bladder cancer.
    Arab J Urol. 2015;13:233-237.
    Abstract     Related articles   

  598. CHEN K, Li BK, Xu K, Xu AB, et al
    [Effect of stable DNA methyltransferase 3bknockdown on proliferation and apoptosis in bladder cancer cells in vitro].
    Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:1524-1529.
    Abstract     Related articles   

  599. GAUTAM KA, Muktanand T, Sankhwar SN, Goel A, et al
    Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Cytokine. 2015;77:152-156.
    Abstract     Related articles   

  600. GREGG JR, Dahm P, Chang SS
    Guideline-based management of non-muscle invasive bladder cancer.
    Indian J Urol. 2015;31:320-326.
    Abstract     Related articles   

  601. BROOKS NA, O'Donnell MA
    Treatment options in non-muscle-invasive bladder cancer after BCG failure.
    Indian J Urol. 2015;31:312-319.
    Abstract     Related articles   

  602. JOKISCH JF, Karl A, Stief C
    Intravesical immunotherapy in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:304-311.
    Abstract     Related articles   

  603. PORTEN SP, Leapman MS, Greene KL
    Intravesical chemotherapy in non-muscle-invasive bladder cancer.
    Indian J Urol. 2015;31:297-303.
    Abstract     Related articles   

  604. ISHARWAL S, Konety B
    Non-muscle invasive bladder cancer risk stratification.
    Indian J Urol. 2015;31:289-296.
    Abstract     Related articles   

  605. SOUBRA A, Risk MC
    Diagnostics techniques in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:283-288.
    Abstract     Related articles   

  606. DARWICHE F, Parekh DJ, Gonzalgo ML
    Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise.
    Indian J Urol. 2015;31:273-282.
    Abstract     Related articles   

  607. KONETY BR
    Advances in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:272.
    Abstract     Related articles   

  608. DODAGOUDAR C, Doval DC, Mahanta A, Goel V, et al
    FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  609. OZCAN C, Telli O, Ozturk E, Suer E, et al
    The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  610. ABROL S, Jairath A, Ganpule S, Ganpule A, et al
    Can CT Virtual Cystoscopy Replace Conventional Cystoscopy in Early Detection of Bladder Cancer?
    Adv Urol. 2015;2015:926590.
    Abstract     Related articles   

  611. ZHAO Y, Qi JG, Yang N, Lin YL, et al
    Association between MYC rs9642880[T] allele and bladder cancer risk: a meta-analysis.
    Genet Mol Res. 2015;14:14745-51.
    Abstract     Related articles   

  612. ZHAO T, Wu X, Liu J
    Association between interleukin-22 genetic polymorphisms and bladder cancer risk.
    Clinics (Sao Paulo). 2015;70:686-90.
    Abstract     Related articles   

  613. TRABOULSI SL, Kassouf W
    Bladder cancer: A step closer to individualized treatment for bladder cancer.
    Nat Rev Urol. 2015 Nov 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  614. WITJES JA
    Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy.
    Nat Rev Urol. 2015 Nov 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

    The state and potential of social media in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  616. KISS B, Burkhard FC, Thalmann GN
    Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  617. WU H, Wang X, Zhang L, Mo N, et al
    Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Clin Genitourin Cancer. 2015 Oct 26. pii: S1558-7673(15)00263.
    Abstract     Related articles   

  618. CROZIER J, Papa N, Sengupta S, Bolton DM, et al
    Changing practice of pelvic lymph node dissection in management of primary bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  619. CHOU R, Buckley D, Fu R, Gore JL, et al
    The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer.
    Radiother Oncol. 2015 Nov 26. pii: S0167-8140(15)00594.
    Abstract     Related articles   

  620. FENG C, Wang L, Ding G, Jiang H, et al
    BLCA1 expression is associated with angiogenesis of bladder cancer and is correlated with common pro-angiogenic factors.
    Int J Clin Exp Med. 2015;8:16259-16265.
    Abstract     Related articles   

  621. DING M, Li Y, Wang H, Lv Y, et al
    Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
    Int J Clin Exp Med. 2015;8:15432-15440.
    Abstract     Related articles   

  622. MESSINA C, Zanardi E, Dellepiane C, Tomasello L, et al
    A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.
    Clin Genitourin Cancer. 2015 Oct 28. pii: S1558-7673(15)00268.
    Abstract     Related articles   

  623. WU S, Yang Z, Ye R, An D, et al
    Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.
    Oncotarget. 2015 Nov 25. doi: 10.18632/oncotarget.6380.
    Abstract     Related articles   

  624. AZUMA T, Nagase Y, Oshi M
    Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin.
    Mol Clin Oncol. 2015;3:1113-1116.
    Abstract     Related articles   

  625. ZHANG HH, Qi F, Cao YH, Zu XB, et al
    Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.
    Oncol Lett. 2015;10:2610-2616.
    Abstract     Related articles   

  626. CAI T, Mondaini N, Tiscione D, Dal Canto M, et al
    Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history.
    Oncol Lett. 2015;10:2569-2573.
    Abstract     Related articles   

  627. RICCI S, Bruzzese D, DI Carlo A
    Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.
    Oncol Lett. 2015;10:2527-2532.
    Abstract     Related articles   

  628. SONG YH, Liao R, Li PC, Ge BO, et al
    Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C.
    Oncol Lett. 2015;10:2422-2426.
    Abstract     Related articles   

  629. KOBATAKE K, Mita K, Ohara S, Kato M, et al
    Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer.
    Oncol Lett. 2015;10:1097-1102.
    Abstract     Related articles   

  630. LIN YL, Gui SL, Ma JG
    Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
    Oncol Lett. 2015;10:647-652.
    Abstract     Related articles   

  631. ZHAO C, Qi L, Chen M, Liu L, et al
    microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.
    Exp Ther Med. 2015;10:1103-1108.
    Abstract     Related articles   

  632. KNOLLMAN H, Godwin JL, Jain R, Wong YN, et al
    Muscle-invasive urothelial bladder cancer: an update on systemic therapy.
    Ther Adv Urol. 2015;7:312-330.
    Abstract     Related articles   

  633. PAGLIARULO V, Ancona P, Martines I, Spadavecchia R, et al
    Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study.
    Ther Adv Urol. 2015;7:303-311.
    Abstract     Related articles   

  634. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies.
    BMC Genomics. 2015;16:1019.
    Abstract     Related articles   

  635. BAHOUTH Z, Halachmi S, Moskovitz B, Nativ O, et al
    The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2015.
    Abstract     Related articles   

  636. ZHANG Q, Hao C, Cheng G, Wang L, et al
    High CD4(+) T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.
    Int J Clin Exp Pathol. 2015;8:11510-6.
    Abstract     Related articles   

  637. ZHANG Z, Xu Q, Huang X, Yang J, et al
    The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
    Int J Clin Exp Pathol. 2015;8:10283-93.
    Abstract     Related articles   

  638. LI Y, Cheng H, Xu W, Tian X, et al
    Expression of Robo protein in bladder cancer tissues and its effect on the growth of cancer cells by blocking Robo protein.
    Int J Clin Exp Pathol. 2015;8:9932-40.
    Abstract     Related articles   

  639. FAILLIE JL, Hillaire-Buys D
    Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue.
    Pharmacoepidemiol Drug Saf. 2015 Nov 30. doi: 10.1002/pds.3925.
    Abstract     Related articles   

  640. ZHANG S, Pei X, Hu H, Zhang W, et al
    Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  641. BEN FRADJ MK, Kallel A, Gargouri MM, Chehida MA, et al
    Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration.
    Tumour Biol. 2015.
    Abstract     Related articles   

  642. JONES RT, Felsenstein KM, Theodorescu D
    Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.
    Urol Clin North Am. 2016;43:77-86.
    Abstract     Related articles   

  643. NETTO GJ, Tafe LJ
    Emerging Bladder Cancer Biomarkers and Targets of Therapy.
    Urol Clin North Am. 2016;43:63-76.
    Abstract     Related articles   

  644. MBEUTCHA A, Lucca I, Mathieu R, Lotan Y, et al
    Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
    Urol Clin North Am. 2016;43:47-62.
    Abstract     Related articles   

  645. KIM GY, Park SY, Jo A, Kim M, et al
    Erratum to: Gecko proteins induce the apoptosis of bladder cancer 5637 cells by inhibiting Akt and activating the intrinsic caspase cascade.
    BMB Rep. 2015;48:642.
    Abstract     Related articles   

  646. SOLOMON JP, Hansel DE
    Morphologic and Molecular Characteristics of Bladder Cancer.
    Surg Pathol Clin. 2015;8:663-76.
    Abstract     Related articles   

  647. SAVINA NV, Nikitchenko NV, Kuzhir TD, Rolevich AI, et al
    The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.
    Oxid Med Cell Longev. 2016;2016:5710403.
    Abstract     Related articles   

  648. SUN DK, Wang JM, Zhang P, Wang YQ, et al
    MicroRNA-138 Regulates Metastatic Potential of Bladder Cancer Through ZEB2.
    Cell Physiol Biochem. 2015;37:2366-2374.
    Abstract     Related articles   

  649. LACOMBE L, Fradet V, Levesque E, Pouliot F, et al
    Phase II drug metabolizing polymorphisms and smoking status predict recurrence of non-muscle invasive bladder cancer: a gene-smoking interaction.
    Cancer Prev Res (Phila). 2015 Dec 8. pii: canprevres.0069.2015.
    Abstract     Related articles   

  650. WANG C, Ge Q, Chen Z, Hu J, et al
    Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 expression.
    Tumour Biol. 2015.
    Abstract     Related articles   

  651. JURI H, Tsuboyama T, Kumano S, Inada Y, et al
    Detection of Bladder Cancer: Comparison of Low-Dose Scans with AIDR 3D and Routine-Dose Scans with FBP on the Excretory Phase in CT Urography.
    Br J Radiol. 2015 Dec 7:20150495.
    Abstract     Related articles   

  652. KONG D, Chen F, Sima NI
    Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway.
    Exp Ther Med. 2015;10:1725-1731.
    Abstract     Related articles   

  653. HEYES SM, Bond MJ, Harrington A, Belan I, et al
    The relative contributions of function, perceived psychological burden and partner support to cognitive distress in bladder cancer.
    Psychooncology. 2015 Dec 7. doi: 10.1002/pon.4054.
    Abstract     Related articles   

  654. NARAYAN V, Mamtani R, Keefe S, Guzzo T, et al
    Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.
    Cancer Res Treat. 2015 Dec 2. doi: 10.4143/crt.2015.
    Abstract     Related articles   

  655. HU H, Zhao J, Zhang M
    Expression of Annexin A2 and Its Correlation With Drug Resistance and Recurrence of Bladder Cancer.
    Technol Cancer Res Treat. 2015 Dec 4. pii: 1533034615617078.
    Abstract     Related articles   

  656. AFONSO J, Santos LL, Morais A, Amaro T, et al
    Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumour aggressiveness.
    Cell Cycle. 2015.
    Abstract     Related articles   

  657. ETHUG H, Jagodic S, Ahmetovic-Ethug J, Selimovic Z, et al
    Predicting recurrence of non-muscle-invasive bladder cancer after transurethral resection.
    Med Glas (Zenica). 2016;13.
    Abstract     Related articles   

  658. WAN B, Tan J, Zeng Q, He LY, et al
    729G/C polymorphism in Toll-like receptor 4 results in increased susceptibility to bladder cancer.
    Genet Mol Res. 2015;14:15482-7.
    Abstract     Related articles   

  659. SHEN B, Tan M, Mu X, Qin Y, et al
    Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  660. KISELYOV A, Bunimovich-Mendrazitsky S, Startsev V
    Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies.
    BBA Clin. 2015;4:27-34.
    Abstract     Related articles   

  661. XIE L, Sun Y, Chen T, Tian D, et al
    Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis.
    Onco Targets Ther. 2015;8:3679-3690.
    Abstract     Related articles   

  662. HIRAIWA T, Mori T, Ohashi T, Hanami Y, et al
    Eosinophilic fasciitis with severe joint contracture in a patient with bladder cancer and B-cell lymphoma.
    J Dermatol. 2015 Dec 15. doi: 10.1111/1346-8138.13233.
    Abstract     Related articles   

  663. OGIHARA K, Kikuchi E, Yuge K, Ito Y, et al
    Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  664. FERRARA A, Lewis JD, Habel LA
    Pioglitazone Use and Risk of Bladder Cancer-Reply.
    JAMA. 2015;314:2568-2569.
    Abstract     Related articles   

  665. DAVIES BJ
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2568.
    Abstract     Related articles   

  666. SINGH S, Suchard MA
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2567-2568.
    Abstract     Related articles   

  667. LIU CAI-SHU, Cai S, Zhang YP, Yan HY, et al
    [Present Situation and Prospect of Urinary Biomarkers For Bladder Cancer].
    Sheng Li Ke Xue Jin Zhan. 2015;46:255-8.
    Abstract     Related articles   

  668. ALFANO M, Canducci F, Nebuloni M, Clementi M, et al
    The interplay of extracellular matrix and microbiome in urothelial bladder cancer.
    Nat Rev Urol. 2015 Dec 15. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  669. GUNLUSOY B, Ceylan Y, Degirmenci T, Kozacioglu Z, et al
    Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  670. KASSOUF W, Traboulsi SL, Kulkarni GS, Breau RH, et al
    CUA guidelines on the management of non-muscle invasive bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  671. KARKOULIS PK, Stravopodis DJ, Voutsinas GE
    17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  672. CAO YH, Zhang HH, Xu HF, Duan YJ, et al
    Prognostic role of microRNA-100 in patients with bladder cancer.
    Genet Mol Res. 2015;14:15948-15954.
    Abstract     Related articles   

  673. KRPINA K, Babarovic E, Spanjol J, Dordevic G, et al
    Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.
    Wien Klin Wochenschr. 2015.
    Abstract     Related articles   

  674. ZHANG X, Zhang Y, Liu X, Fang A, et al
    Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Oncotarget. 2015 Dec 7. doi: 10.18632/oncotarget.6487.
    Abstract     Related articles   

  675. LI CC, Yang JC, Lu MC, Lee CL, et al
    ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.
    Oncotarget. 2015 Dec 5. doi: 10.18632/oncotarget.6482.
    Abstract     Related articles   

  676. CLARK PE
    Toward Personalized Guidelines in Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1458-60.
    Abstract     Related articles   

  677. ZENG S, Yu X, Ma C, Zhang Z, et al
    Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Medicine (Baltimore). 2015;94:e2176.
    Abstract     Related articles   

  678. PENG XC, Gong FM, Chen Y, Qiu M, et al
    Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
    J Proteomics. 2015 Dec 3. pii: S1874-3919(15)30177.
    Abstract     Related articles   

  679. SAKR SA, Mahran HA, Fahmy AM, El-Kholy MA, et al
    Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2.
    Biomed Pharmacother. 2015;76:73-81.
    Abstract     Related articles   

  680. DABROWSKA M, Drabarek T, Muraszko-Klaudel A, Slawek J, et al
    A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.
    Neurol Neurochir Pol. 2015;49:460-466.
    Abstract     Related articles   

  681. CHOU R, Buckley D, Fu R, Gore JL, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 37-2015. A 76-Year-Old Man with Fevers, Leukopenia, and Pulmonary Infiltrates.
    N Engl J Med. 2015;373:2162-72.
    Abstract     Related articles   

  682. DRAGOVIC T, Marinkovic D, Kuzmic-Jankovic S, Prelevic R, et al
    Unrecognised adrenergic symptoms and the delayed diagnosis of urinary bladder paraganglioma.
    Vojnosanit Pregl. 2015;72:831-6.
    Abstract     Related articles   

  683. KAMAL AM, Wishahi M, Nour HH, Elganzoury H, et al
    J Egypt Soc Parasitol. 2015;45:429-33.
    Abstract     Related articles   

  684. MINA SN, Antonios SN
    J Egypt Soc Parasitol. 2015;45:385-8.
    Abstract     Related articles   

  685. HASEGAWA Y, Komasawa N, Matsunami S, Kido H, et al
    [Rapid Sequence Intubation with the McGRATH MAC Videolaryngoscope in the Sitting Position for a Patient with Restricted Mouth Opening].
    Masui. 2015;64:632-4.
    Abstract     Related articles   

  686. BANNO E, Nishino A, Nagai Y, Yasuda M, et al
    Nihon Hinyokika Gakkai Zasshi. 2015;106:206-10.
    Abstract     Related articles   

  687. MENG YS, Su Y, Fan Y, Yu W, et al
    [Risk factors for the development of postoperative paralytic ileus after radical cystectomy: a report of 740 cases].
    Beijing Da Xue Xue Bao. 2015;47:628-33.
    Abstract     Related articles   

  688. LIU YQ, Lu J, Zhao L, Hou XF, et al
    [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
    Beijing Da Xue Xue Bao. 2015;47:605-10.
    Abstract     Related articles   

  689. BRIMO F, Dauphin-Pierre S, Aprikian A, Kassouf W, et al
    Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant.
    Hum Pathol. 2015;46:1506-13.
    Abstract     Related articles   

  690. KIM K, Sung CO, Park BH, Ku JY, et al
    Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
    Hum Pathol. 2015;46:1464-70.
    Abstract     Related articles   

  691. BOUCHER M, Bryan S, Dukes S
    Deficiency or dementia? Exploring B12 deficiency after urostomy.
    Br J Nurs. 2015;24:594-7.
    Abstract     Related articles   

  692. MATOSO A, Epstein JI
    Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
    Am J Surg Pathol. 2015;39:1377-82.
    Abstract     Related articles   

  693. ADDING C, Collins JW, Laurin O, Hosseini A, et al
    Enhanced recovery protocols (ERP) in robotic cystectomy surgery. Review of current status and trends.
    Curr Urol Rep. 2015;16:32.
    Abstract     Related articles   

  694. SUKHA A, Smyth N
    Fistula formation between the external iliac artery and ileal conduit following a radical cystoprostatectomy: a rare complication with prewarning signs of haemorrhage.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  695. LIN YH, Peng PY
    Semiconductor sensor embedded microfluidic chip for protein biomarker detection using a bead-based immunoassay combined with deoxyribonucleic acid strand labeling.
    Anal Chim Acta. 2015;869:34-42.
    Abstract     Related articles   

  696. FERNANDEZ-PINEDA I, McCarville MB, Brennan RC, Spunt SL, et al
    Bilateral internal hemipelvectomy for osteosarcoma in a pediatric patient previously treated for rhabdomyosarcoma.
    Orthop Traumatol Surg Res. 2015;101:395-7.
    Abstract     Related articles   

  697. ZYCZKOWSKI M, Muskala B, Kaletka Z, Bryniarski P, et al
    Sacrocolpopexy with polypropylene tape as valuable surgical modification during cystectomy with orthotopic ileal bladder: functional results.
    Biomed Res Int. 2015;2015:306191.
    Abstract     Related articles   

  698. TOMASZEWSKI JJ, Smaldone MC
    Perioperative strategies to reduce postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:26.
    Abstract     Related articles   

  699. TYSON MD, Wisenbaugh ES, Patton M, Salevitz D, et al
    Postoperative changes in serum CO2 as an indicator of postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:25.
    Abstract     Related articles   

  700. OH KJ, Choi YD, Chung HS, Hwang EC, et al
    A novel transurethral resection technique for superficial flat bladder tumor: grasp and bite technique.
    Korean J Urol. 2015;56:227-32.
    Abstract     Related articles   

  701. KOJIMA Y, Takahi Y, Ichimaru N, Okumi M, et al
    Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
    BMC Res Notes. 2015;8:25.
    Abstract     Related articles   

  702. BUNIMOVICH-MENDRAZITSKY S, Pisarev V, Kashdan E
    Modeling and simulation of a low-grade urinary bladder carcinoma.
    Comput Biol Med. 2015;58:118-29.
    Abstract     Related articles   

  703. CHANG CH, Chan PC, Li JR, Chen CJ, et al
    Gab1 is essential for membrane translocation, activity and integrity of mTORCs after EGF stimulation in urothelial cell carcinoma.
    Oncotarget. 2015;6:1478-89.
    Abstract     Related articles   

  704. MICHAILIDI C, Hayashi M, Datta S, Sen T, et al
    Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
    Cancer Prev Res (Phila). 2015;8:208-21.
    Abstract     Related articles   

  705. BAGLO Y, Peng Q, Hagen L, Berg K, et al
    Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model.
    Photodiagnosis Photodyn Ther. 2015;12:58-66.
    Abstract     Related articles   

  706. ABOUMARZOUK O, Valentine R, Buist R, Ahmad S, et al
    Laser-induced autofluorescence spectroscopy: can it be of importance in detection of bladder lesions?
    Photodiagnosis Photodyn Ther. 2015;12:76-83.
    Abstract     Related articles   

  707. NOWAK JM, Klimaszewska-Wisniewska A, Izdebska M, Gagat M, et al
    Gelsolin is a potential cellular target for cotinine to regulate the migration and apoptosis of A549 and T24 cancer cells.
    Tissue Cell. 2015;47:105-14.
    Abstract     Related articles   

  708. CHOO MS, Jeong CW, Kwak C, Kim HH, et al
    Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis.
    Clin Genitourin Cancer. 2015;13:e113-21.
    Abstract     Related articles   

  709. NECCHI A, Pond GR, Giannatempo P, Di Lorenzo G, et al
    Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy.
    Clin Genitourin Cancer. 2015;13:178-84.
    Abstract     Related articles   

  710. BIGUM LH, Spielmann ME, Juhl G, Rasmussen A, et al
    A qualitative study exploring male cancer patients' experiences with percutaneous nephrostomy.
    Scand J Urol. 2015;49:162-8.
    Abstract     Related articles   

  711. BOUAZIZ O, Guilloux A
    A penalized algorithm for event-specific rate models for recurrent events.
    Biostatistics. 2015;16:281-94.
    Abstract     Related articles   

    Editorial comment for Sim et al.
    J Endourol. 2015;29:390.
    Abstract     Related articles   

  713. YANG YH, Zhu Y, Zhu XW, Tang HJ, et al
    Unusual presentation of urachal adenocarcinoma with genitourinary cutaneous metastasis.
    Asian J Androl. 2015;17:339-40.
    Abstract     Related articles   

  714. JENSEN BT, Petersen AK, Jensen JB, Laustsen S, et al
    Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: a prospective randomized controlled trial.
    Scand J Urol. 2015;49:133-41.
    Abstract     Related articles   

  715. NECCHI A, Giannatempo P, Paolini B, Lo Vullo S, et al
    Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.
    Clin Genitourin Cancer. 2015;13:171-7.
    Abstract     Related articles   

  716. PIANA S, Bernardi C, Zoino JL
    Itchy erythroderma in a neoplastic patient-mind the mite!
    Eur J Intern Med. 2015;26:139-40.
    Abstract     Related articles   

  717. RICHARDS KA, Cohn JA, Large MC, Bales GT, et al
    The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy.
    Urol Oncol. 2015;33:65.
    Abstract     Related articles   

  718. MITIN T, George A, Zietman AL, Heney NM, et al
    Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
    Int J Radiat Oncol Biol Phys. 2016;94:67-74.
    Abstract     Related articles   

  719. MA L, Xu Z, Xu C, Jiang X, et al
    MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  720. BEN BAHRIA-SEDIKI I, Sampaio C, Chebil M, Cherif M, et al
    Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  721. WANG Y, Yu Y, Ye R, Zhang D, et al
    An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese.
    Oncotarget. 2015 Dec 19. doi: 10.18632/oncotarget.6666.
    Abstract     Related articles   

  722. SANTOS F, Dragomir A, Zakaria AS, Kassouf W, et al
    Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.
    J Surg Oncol. 2015 Dec 22. doi: 10.1002/jso.24132.
    Abstract     Related articles   

  723. ZHONG J, Chen Y, Liao X, Li J, et al
    Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  724. KAWAHARA T, Ide H, Kashiwagi E, Patterson JD, et al
    Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.
    Am J Cancer Res. 2015;5:2959-68.
    Abstract     Related articles   

  725. RORBACH-DOLATA A, Marchewka Z, Piwowar A
    [The biochemical carcinogenesis of selected heavy metals in bladder cancer].
    Postepy Biochem. 2015;61:176-82.
    Abstract     Related articles   

  726. HERNANDEZ V, Llorente C, de la Pena E, Perez-Fernandez E, et al
    Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer.
    Urol Oncol. 2015 Dec 10. pii: S1078-1439(15)00557.
    Abstract     Related articles   

  727. ABRO S, Clark M, Barkan G, Hoppensteadt D, et al
    Inflammation and Hemostatic Activation may Contribute to Postsurgical Thrombosis in Patients With Bladder Cancer.
    Clin Appl Thromb Hemost. 2015 Dec 17. pii: 1076029615622000.
    Abstract     Related articles   

  728. SHI Z, Li X, Wu D, Tang R, et al
    Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  729. CROZIER J, Demkiw S, Lawrentschuk N
    Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  730. SALMINEN AP, Jambor I, Syvanen KT, Bostrom PJ, et al
    Lymph node imaging in bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  731. SHEN H, Blijlevens M, Yang N, Frangou C, et al
    Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.
    Int J Biol Sci. 2015;11:1363-75.
    Abstract     Related articles   

  732. MIYATA Y, Sakai H
    Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.
    Dis Markers. 2015;2015:857416.
    Abstract     Related articles   

  733. AN Y, Li H, Wang KJ, Liu XH, et al
    Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
    Genet Mol Res. 2015;14:16896-904.
    Abstract     Related articles   

  734. KLAASSEN Z, DiBianco JM, Jen RP, Harper B, et al
    The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer.
    J Wound Ostomy Continence Nurs. 2015.
    Abstract     Related articles   

  735. CHIU KY, Wu CC, Chia CH, Hsu SL, et al
    Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.
    Cancer Lett. 2015 Dec 8. pii: S0304-3835(15)00736.
    Abstract     Related articles   

  736. CHOU R, Buckley D, Fu R, Gore JL, et al
    Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.
    Medicine (Baltimore). 2015;94:e1494.
    Abstract     Related articles   

  737. LUO Y, She DL, Xiong H, Fu SJ, et al
    The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.
    Medicine (Baltimore). 2015;94:e1523.
    Abstract     Related articles   

  738. AHMAD I
    The role of WNT signalling in urothelial cell carcinoma.
    Ann R Coll Surg Engl. 2015;97:481-6.
    Abstract     Related articles   

  739. WANG X, Xu S, Tang D, Gu W, et al
    Malignant Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a 14-Year-Old Boy.
    J Pediatr Hematol Oncol. 2015;37:e402-4.
    Abstract     Related articles   

    Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
    Asian Pac J Cancer Prev. 2015;16:2871-7.
    Abstract     Related articles   

  741. CATHOMAS R, De Santis M, Galsky MD
    First-line treatment of metastatic disease: cisplatin-ineligible patients.
    Hematol Oncol Clin North Am. 2015;29:329-40.
    Abstract     Related articles   

  742. JANI AB, Efstathiou JA, Shipley WU
    Bladder preservation strategies.
    Hematol Oncol Clin North Am. 2015;29:289-300.
    Abstract     Related articles   

  743. WEIJERS Y, Arentsen HC, Arends TJ, Witjes JA, et al
    Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma.
    Hematol Oncol Clin North Am. 2015;29:219-25.
    Abstract     Related articles   

  744. CHI BH, Kim SJ, Seo HK, Seo HH, et al
    P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
    J Korean Med Sci. 2015;30:308-16.
    Abstract     Related articles   

  745. ROSSI L, Santoni M, Crabb SJ, Scarpi E, et al
    High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Ann Surg Oncol. 2015;22:1377-84.
    Abstract     Related articles   

  746. Re: "Is the Inverse Association Between Selenium and Bladder Cancer Due to Confounding by Smoking?".
    Am J Epidemiol. 2015;182:280.
    Abstract     Related articles   

  747. GOOSSENS ME, Brinkman M, Zeegers MP, Buntinx F, et al
    Am J Epidemiol. 2015.
    Abstract     Related articles   

  748. ECKE TH, Arndt C, Stephan C, Hallmann S, et al
    Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder Cancer.
    Anticancer Res. 2015;35:2651-5.
    Abstract     Related articles   

  749. SULE N, Xu BO, El Zein D, Szigeti K, et al
    Radiation-induced Chondrosarcoma of the Bladder. Case Report and Review of Literature.
    Anticancer Res. 2015;35:2857-60.
    Abstract     Related articles   

  750. NOEL N, Couteau J, Maillet G, Gobet F, et al
    TP53 and FGFR3 Gene Mutation Assessment in Urine: Pilot Study for Bladder Cancer Diagnosis.
    Anticancer Res. 2015;35:4915-21.
    Abstract     Related articles   

  751. LEA MA, Altayyar M, desBORDES C
    Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism.
    Anticancer Res. 2015;35:5889-99.
    Abstract     Related articles   

    Could a dye offer a cheap and simple approach to detect bladder cancer using white-light cystoscopy?
    BJU Int. 2015 May 8. doi: 10.1111/bju.13177.
    Abstract     Related articles   

  753. BAACK KUKREJA JE, Scosyrev E, Brasacchio RA, Toy EP, et al
    Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
    BJU Int. 2014;114:844-51.
    Abstract     Related articles   

  754. TOLCHARD S, Angell J, Pyke M, Lewis S, et al
    Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
    BJU Int. 2015;115:554-61.
    Abstract     Related articles   

  755. LUCCA I, Roupret M, Kluth L, Rink M, et al
    Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    BJU Int. 2015;115:722-7.
    Abstract     Related articles   

  756. LEOW JJ, Reese S, Trinh QD, Bellmunt J, et al
    Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    BJU Int. 2015;115:713-21.
    Abstract     Related articles   

  757. ISHIOKA J, Saito K, Kijima T, Nakanishi Y, et al
    Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    BJU Int. 2015;115:705-12.
    Abstract     Related articles   

  758. PHE V, Roupret M, Cussenot O, Chartier-Kastler E, et al
    Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    BJU Int. 2015;115 Suppl 6:28-32.
    Abstract     Related articles   

  759. GAKIS G, Stenzl A
    Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    BJU Int. 2015;116:3-4.
    Abstract     Related articles   

  760. O'REGAN T, Tatton M, Lyon M, Masters J, et al
    The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: A New Zealand Perspective.
    BJU Int. 2015 Jul 14. doi: 10.1111/bju.13211.
    Abstract     Related articles   

  761. ROSE JB, Armstrong S, Hermann GG, Kjellberg J, et al
    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue- light cystoscopy in trans-urethral bladder tumour resection for non-muscle invasive bladder cancer patients in Sweden.
    BJU Int. 2015 Aug 25. doi: 10.1111/bju.13261.
    Abstract     Related articles   

  762. PATEL MI, Bang A, Gillatt D, Smith DP, et al
    Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    BJU Int. 2015 Sep 2. doi: 10.1111/bju.13152.
    Abstract     Related articles   

  763. WITJES JA
    Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
    BJU Int. 2015;116:2-3.
    Abstract     Related articles   

  764. VON RUNDSTEDT FC, Mata DA, Groshen S, Stein JP, et al
    Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
    BJU Int. 2015;116:44-9.
    Abstract     Related articles   

  765. ALBISINNI S, Rassweiler J, Abbou CC, Cathelineau X, et al
    Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.
    BJU Int. 2015;115:937-45.
    Abstract     Related articles   

  766. VOSKOBOYNIK M, Rudman S, Arkenau HT, Hughes S, et al
    Immunotherapy for Bladder Cancer: Rediscovering an Old Friend.
    BJU Int. 2015 Sep 21. doi: 10.1111/bju.13330.
    Abstract     Related articles   

  767. RAMIREZ D, Gupta A, Canter D, Harrow B, et al
    Microscopic hematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    BJU Int. 2015 Oct 5. doi: 10.1111/bju.13345.
    Abstract     Related articles   

  768. WARREN H, Raison N, Dasgupta P
    Pioglitazone and Bladder Cancer.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13352.
    Abstract     Related articles   

  769. MULLER J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, et al
    Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351.
    Abstract     Related articles   

  770. LOEB S, Ribal MJ
    Controversies in management of high-risk prostate and bladder cancer.
    BJU Int. 2015;116:675.
    Abstract     Related articles   

  771. GENDY R, Delprado W, Brenner P, Brooks A, et al
    Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    BJU Int. 2015 Oct 21. doi: 10.1111/bju.13265.
    Abstract     Related articles   

  772. WILLIAMS SB, Kamat AM, Lamm DL
    Pelvic recurrence after radical cystectomy: a call to arms.
    BJU Int. 2015;116:172-3.
    Abstract     Related articles   

  773. TURATI F, Polesel J, Di Maso M, Montella M, et al
    Diabetes mellitus and the risk of bladder cancer: an Italian case-control study.
    Br J Cancer. 2015 May 21. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  774. MATSUSHITA R, Seki N, Chiyomaru T, Inoguchi S, et al
    Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
    Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  775. KHADJAVI A, Mannu F, Destefanis P, Sacerdote C, et al
    Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  776. BLICK C, Ramachandran A, McCormick R, Wigfield S, et al
    Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis.
    Br J Cancer. 2015 Jul 21. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  777. BHINDI B, Hermanns T, Wei Y, Yu J, et al
    Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Br J Cancer. 2015 Dec 10. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  778. GREEN AK, Milowsky MI
    Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29825.
    Abstract     Related articles   

  779. HE F, Melamed J, Tang MS, Huang C, et al
    Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.
    Cancer Res. 2015;75:2017-28.
    Abstract     Related articles   

  780. PALMBOS PL, Wang L, Yang H, Wang Y, et al
    ATDC/TRIM29 drives invasive bladder cancer formation through microRNA-mediated and epigenetic mechanisms.
    Cancer Res. 2015 Oct 15. pii: canres.0603.2015.
    Abstract     Related articles   

  781. LI C, Du Y, Yang Z, He L, et al
    GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells.
    Cancer Res. 2015 Dec 16. pii: canres.2309.2015.
    Abstract     Related articles   

  782. WANG H, Wang Y, Kota KK, Kallakury B, et al
    Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian.
    Carcinogenesis. 2015.
    Abstract     Related articles   

  783. LEE SR, Roh YG, Kim SK, Lee JS, et al
    Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer.
    Clin Cancer Res. 2015 Aug 12. pii: clincanres.2680.2014.
    Abstract     Related articles   

  784. SVATEK RS, Zhao XR, Morales EE, Jha MK, et al
    Sequential intravesical mitomycin plus Bacillus Calmette-Guerin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial.
    Clin Cancer Res. 2015;21:303-11.
    Abstract     Related articles   

  785. SHAPIRO GI, Kwak E, Dezube BJ, Yule M, et al
    First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors.
    Clin Cancer Res. 2015;21:87-97.
    Abstract     Related articles   

  786. KIM J, Akbani R, Creighton CJ, Lerner SP, et al
    Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.
    Clin Cancer Res. 2015;21:4514-24.
    Abstract     Related articles   

  787. KIM HS, Jeong CW, Kwak C, Kim HH, et al
    Pathological T0 following cisplatin-based neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a network meta-analysis.
    Clin Cancer Res. 2015 Oct 26. pii: clincanres.1208.2015.
    Abstract     Related articles   

  788. NOGUCHI M, Matsumoto K, Uemura H, Arai G, et al
    An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
    Clin Cancer Res. 2015.
    Abstract     Related articles   

  789. GHASEMZADEH A, Bivalacqua TJ, Hahn NM, Drake CG, et al
    New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
    Clin Cancer Res. 2015 Dec 18. pii: clincanres.1135.2015.
    Abstract     Related articles   

  790. ROSE TL, Milowsky MI
    Management of muscle-invasive bladder cancer in the elderly.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  791. MATHIEU R, Lucca I, Klatte T, Babjuk M, et al
    Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  792. DIBIANCO JM, George AK, Su D, Agarwal PK, et al
    Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  793. WOLFF I, Brookman-May S, May M
    Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  794. APOLO AB, Burger M
    A precision, personalized approach to the management of bladder cancer.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  795. MCCONKEY DJ, Choi W, Dinney CP
    Genetic subtypes of invasive bladder cancer.
    Curr Opin Urol. 2015;25:449-58.
    Abstract     Related articles   

  796. FAKHREJAHANI F, Tomita Y, Maj-Hes A, Trepel JB, et al
    Immunotherapies for bladder cancer: a new hope.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  797. NIVER BE, Daneshmand S, Satkunasivam R
    Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes.
    Curr Opin Urol. 2015;25:105-10.
    Abstract     Related articles   

  798. KNOEDLER J, Frank I
    Organ-sparing surgery in urology: partial cystectomy.
    Curr Opin Urol. 2015;25:111-5.
    Abstract     Related articles   

  799. GO H, Kim PJ, Jeon YK, Cho YM, et al
    Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Eur J Cancer. 2015;51:1937-45.
    Abstract     Related articles   

  800. NAVAI N, Matin SF
    Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy.
    Eur Urol. 2015;67:173-4.
    Abstract     Related articles   

  801. GOFRIT ON
    Re: Long-Term Outcomes in Patients with Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233.
    Eur Urol. 2015;68:165-6.
    Abstract     Related articles   

  802. GIANNARINI G, Palumbo V, Ficarra V
    Words of Wisdom. Re: robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients.
    Eur Urol. 2015;67:1191-2.
    Abstract     Related articles   

  803. DE MARTINO M, Lucca I, Mbeutcha A, Wiener HG, et al
    Carbonic Anhydrase IX as a Diagnostic Urinary Marker for Urothelial Bladder Cancer.
    Eur Urol. 2015 Jun 29. pii: S0302-2838(15)00518.
    Abstract     Related articles   

  804. POURMALEK F, Abdi H, Black PC
    Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.02.003.
    Eur Urol. 2015 Jul 13. pii: S0302-2838(15)00559.
    Abstract     Related articles   

  805. FROEHNER M, Koch R, Heberling U, Novotny V, et al
    Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Eur Urol. 2015 Jul 17. pii: S0302-2838(15)00564.
    Abstract     Related articles   

  806. NGUYEN DP, Scherr DS
    Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol.
    Eur Urol. 2015 Jul 14. pii: S0302-2838(15)00558.
    Abstract     Related articles   

  807. AINE M, Eriksson P, Liedberg F, Hoglund M, et al
    On Molecular Classification of Bladder Cancer: Out of One, Many.
    Eur Urol. 2015 Jul 24. pii: S0302-2838(15)00666.
    Abstract     Related articles   

  808. CAMBIER S, Sylvester RJ, Collette L, Gontero P, et al
    EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin.
    Eur Urol. 2015 Jul 22. pii: S0302-2838(15)00556.
    Abstract     Related articles   

  809. PLIMACK ER, Dunbrack RL, Brennan TA, Andrake MD, et al
    Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.
    Eur Urol. 2015 Jul 31. pii: S0302-2838(15)00613.
    Abstract     Related articles   

  810. BLACK PC
    Fine-tuning Risk Stratification for Non-Muscle-invasive Bladder Cancer.
    Eur Urol. 2015 Aug 6. pii: S0302-2838(15)00693.
    Abstract     Related articles   

  811. RENTSCH CA, Stenner F, Ruiz C, Bubendorf L, et al
    Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep.
    Eur Urol. 2015 Aug 13. pii: S0302-2838(15)00709.
    Abstract     Related articles   

  812. MORALES EE, Grill S, Svatek RS, Kaushik D, et al
    Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.
    Eur Urol. 2015 Aug 27. pii: S0302-2838(15)00772.
    Abstract     Related articles   

  813. ROSE TL, Milowsky MI
    A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer - At What Cost?
    Eur Urol. 2015 Sep 4. pii: S0302-2838(15)00784.
    Abstract     Related articles   

  814. DOBRUCH J, Daneshmand S, Fisch M, Lotan Y, et al
    Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
    Eur Urol. 2015 Sep 4. pii: S0302-2838(15)00782.
    Abstract     Related articles   

    Finasteride and Bladder Cancer.
    Eur Urol. 2015 Sep 10. pii: S0302-2838(15)00858.
    Abstract     Related articles   

  816. SONPAVDE G, Pond GR, Bellmunt J
    Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer - At What Cost? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.08.039: Combination Chemotherapy as a
    Eur Urol. 2015 Sep 23. pii: S0302-2838(15)00909.
    Abstract     Related articles   

  817. SONPAVDE G, Nix JW
    The Neoadjuvant Paradigm for Development of Systemic Therapy and Precision Medicine for Bladder Cancer.
    Eur Urol. 2015 Sep 20. pii: S0302-2838(15)00912.
    Abstract     Related articles   

  818. LEAL J, Luengo-Fernandez R, Sullivan R, Witjes JA, et al
    Economic Burden of Bladder Cancer Across the European Union.
    Eur Urol. 2015 Oct 24. pii: S0302-2838(15)01005.
    Abstract     Related articles   

    Variation in Bladder Cancer Spending: A Global Call to Action.
    Eur Urol. 2015 Nov 19. pii: S0302-2838(15)01084.
    Abstract     Related articles   

  820. CHAN KG, Guru K, Wiklund P, Catto J, et al
    Robot-assisted radical cystectomy and urinary diversion: technical recommendations from the Pasadena Consensus Panel.
    Eur Urol. 2015;67:423-31.
    Abstract     Related articles   

  821. ARON M, Gill IS
    Robotic radical cystectomy: so far, so good--what next?
    Eur Urol. 2015;67:361-2.
    Abstract     Related articles   

  822. WILSON TG, Guru K, Rosen RC, Wiklund P, et al
    Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.
    Eur Urol. 2015;67:363-75.
    Abstract     Related articles   

  823. NOVARA G, Catto JW, Wilson T, Annerstedt M, et al
    Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.
    Eur Urol. 2015;67:376-401.
    Abstract     Related articles   

  824. YUH B, Wilson T, Bochner B, Chan K, et al
    Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Eur Urol. 2015;67:402-22.
    Abstract     Related articles   

  825. KIM JH, Ku JH
    Re: Edwin E. Morales, Sonja Grill, Robert S. Svatek, et al. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.08.029.
    Eur Urol. 2015 Dec 9. pii: S0302-2838(15)01174.
    Abstract     Related articles   

  826. JONES RJ
    Making trials work in practice: please mind the gap.
    Eur Urol. 2015;67:250-1.
    Abstract     Related articles   

  827. MATULLO G, Naccarati A, Pardini B
    microRNA expression profiling in bladder cancer: The challenge of Next Generation Sequencing in tissues and biofluids.
    Int J Cancer. 2015 Oct 21. doi: 10.1002/ijc.29895.
    Abstract     Related articles   

  828. WANG M, Du M, Ma L, Chu H, et al
    A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating a miR-140-5p binding site.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29978.
    Abstract     Related articles   

  829. MATSUSHIMA M, Kikuchi E, Matsumoto K, Hattori S, et al
    Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
    Int J Oncol. 2015 May 11. doi: 10.3892/ijo.2015.2995.
    Abstract     Related articles   

  830. GAO Y, Guan Z, Chen J, Xie H, et al
    CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Int J Oncol. 2015 Jun 9. doi: 10.3892/ijo.2015.3041.
    Abstract     Related articles   

  831. RIEGER C, Huebner D, Temme A, Wirth MP, et al
    Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Int J Oncol. 2015 Jul 20. doi: 10.3892/ijo.2015.3096.
    Abstract     Related articles   

  832. ZHANG S, Zhang C, Liu W, Zheng W, et al
    MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Int J Oncol. 2015 Aug 7. doi: 10.3892/ijo.2015.3117.
    Abstract     Related articles   

  833. HUANG YT, Cheng CC, Chiu TH, Lai PC, et al
    Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer.
    Int J Oncol. 2015 Sep 11. doi: 10.3892/ijo.2015.3155.
    Abstract     Related articles   

  834. SUN Y, Guan Z, Liang L, Cheng Y, et al
    NF-kappaB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Int J Oncol. 2015 Nov 20. doi: 10.3892/ijo.2015.3256.
    Abstract     Related articles   

  835. ZAHRAN MH
    Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892-3.
    Abstract     Related articles   

  836. EL-GAMAL OM
    Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892.
    Abstract     Related articles   

  837. ZAHRAN MH, El-Hefnawy AS, Zidan EM, El-Bilsha MA, et al
    Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:887-92.
    Abstract     Related articles   

  838. OH JJ, Kang MY, Jo JK, Lee HM, et al
    Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
    Int J Urol. 2015 Aug 20. doi: 10.1111/iju.12901.
    Abstract     Related articles   

    Editorial Comment to Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:61.
    Abstract     Related articles   

  840. PFISTER C, Kerkeni W, Rigaud J, Le Gal S, et al
    Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:53-60.
    Abstract     Related articles   

  841. BALL MW
    Editorial Comment to Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12964.
    Abstract     Related articles   

  842. RICHARDS KA, Ham S, Cohn JA, Steinberg GD, et al
    Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12959.
    Abstract     Related articles   

  843. AKITA H, Okamura T, Nakane A, Kobayashi T, et al
    Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy.
    Int J Urol. 2015;22:234-5.
    Abstract     Related articles   

  844. GINORI A, Barone A, Santopietro R, Barbanti G, et al
    Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:222-5.
    Abstract     Related articles   

  845. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:163-70.
    Abstract     Related articles   

  846. SHIGEHARA K, Namiki M
    Editorial comment to Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:225-6.
    Abstract     Related articles   

  847. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Response to editorial comments to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:172.
    Abstract     Related articles   

  848. GONDO T
    Editorial comment from Dr Gondo to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:171.
    Abstract     Related articles   

  849. TSUZUKI T
    Editorial comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:170-1.
    Abstract     Related articles   

  850. YAGISAWA T, Okumi M, Omoto K, Sawada Y, et al
    Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer.
    Int J Urol. 2015 Dec 21. doi: 10.1111/iju.13034.
    Abstract     Related articles   

  851. HUANG TB, Guo ZF, Zhang XL, Zhang XP, et al
    Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies.
    Int Urol Nephrol. 2014;46:1481-93.
    Abstract     Related articles   

  852. SUER E, Ozcan C, Gokce I, Gulpinar O, et al
    Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
    Int Urol Nephrol. 2014;46:1521-6.
    Abstract     Related articles   

  853. YE J, Xu X, Fan M, Xue D, et al
    AFP-producing urothelial carcinoma of the bladder: a case report.
    Int Urol Nephrol. 2014;46:1527-9.
    Abstract     Related articles   

  854. XU T, Zhu Z, Wang X, Xia L, et al
    Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  855. KOIE T, Ohyama C, Hosogoe S, Yamamoto H, et al
    Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  856. THOMAS C, Giesswein A, Hainz M, Stein R, et al
    Concomitant Gleason Score >/=7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  857. FLOYD MS JR, Khattak AQ
    Total urinary tract exenteration including donor nephrectomy for transitional cell carcinoma 41 years following transplantation.
    Int Urol Nephrol. 2015;47:107-8.
    Abstract     Related articles   

  858. WILLIAMS EM, Higgins JP, Sangoi AR, McKenney JK, et al
    Androgen receptor immunohistochemistry in genitourinary neoplasms.
    Int Urol Nephrol. 2015;47:81-5.
    Abstract     Related articles   

  859. AHMED FO, Hamdan HZ, Abdelgalil HB, Sharfi AA, et al
    A comparison between transabdominal ultrasonographic and cystourethroscopy findings in adult Sudanese patients presenting with haematuria.
    Int Urol Nephrol. 2015;47:223-8.
    Abstract     Related articles   

  860. DJUKIC T, Simic T, Radic T, Matic M, et al
    GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Int Urol Nephrol. 2015;47:625-30.
    Abstract     Related articles   

  861. LU K
    Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.62.2712.
    Abstract     Related articles   

  862. MARTIN-DOYLE W, Orsola A, Bellmunt J
    Reply to K. Lu.
    J Clin Oncol. 2015;33:2716-7.
    Abstract     Related articles   

  863. ATALA A
    Re: Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb.
    J Urol. 2015;193:1061.
    Abstract     Related articles   

  864. ROUANNE M, Lebret T, Courbebaisse M
    Re: Long-term renal function outcomes after radical cystectomy.
    J Urol. 2015;193:1066-7.
    Abstract     Related articles   

  865. CHANG SS
    Re: Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study with Molecular Correlates of Response and Toxicit
    J Urol. 2015;193:1932.
    Abstract     Related articles   

  866. CHANG SS
    Re: long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
    J Urol. 2015;193:1931-2.
    Abstract     Related articles   

  867. HAYASHI T, Seiler R, Oo HZ, Jager W, et al
    Targeting HER2 with T-DM1, an Antibody-cytotoxic Drug Conjugate, is effective in HER2-overexpressing bladder cancer.
    J Urol. 2015 Jun 2. pii: S0022-5347(15)04105-1. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  868. GANGKAK G, Giri V, Yadav SS
    Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56.
    J Urol. 2015 Jun 1. pii: S0022-5347(15)03726-X. doi: 10.1016/j.juro.2015.02.2950
    Abstract     Related articles   

  869. CHANG SS
    Re: Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors.
    J Urol. 2015;194:261.
    Abstract     Related articles   

  870. ZABELL JR, Adejoro O, Konety BR, Weight CJ, et al
    Risk of End-Stage Kidney Disease after Radical Cystectomy According to Urinary Diversion Type.
    J Urol. 2014 Oct 31. pii: S0022-5347(14)04805-8. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  871. HEMDAN T, Malmstrom PU, Jahnson S, Segersten U, et al
    Emmprin expression predict response and survival following cisplatin-containing chemotherapy - A validation study in bladder cancer patients from two randomized studies of cystectomy with and without neoadjuvant chemotherapy.
    J Urol. 2015 Jun 25. pii: S0022-5347(15)04296-2. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  872. CHAN KG, Collins JW, Wiklund NP
    Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion.
    J Urol. 2015;193:1467-9.
    Abstract     Related articles   

  873. FRYE TP, Sadowski DJ, Zahnd WE, Jenkins WD, et al
    Impact of county rurality and urologist density on urological cancer mortality in illinois.
    J Urol. 2015;193:1608-13.
    Abstract     Related articles   

  874. PSUTKA SP, Boorjian SA, Moynagh MR, Schmit GD, et al
    Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
    J Urol. 2015;193:1507-13.
    Abstract     Related articles   

  875. PARKER WP, Ho PL, Melquist JJ, Scott K, et al
    The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival.
    J Urol. 2015;193:1494-9.
    Abstract     Related articles   

  876. SKOLARUS TA, Jacobs BL, Schroeck FR, He C, et al
    Understanding hospital readmission intensity after radical cystectomy.
    J Urol. 2015;193:1500-6.
    Abstract     Related articles   

  877. GEIJSEN ED, de Reijke TM, Koning CC, Zum Vorde Sive Vording PJ, et al
    Combining Mitomycin C and regional 70 MHz hyperthermia in patients with non-muscle invasive bladder cancer: a pilot study.
    J Urol. 2015 Jul 1. pii: S0022-5347(15)04307-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  878. PIERZYNSKI JA, Hildebrandt MA, Kamat AM, Lin J, et al
    Genetic Variants within the Wnt/beta-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.
    J Urol. 2015 Jul 11. pii: S0022-5347(15)04361-X. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  879. BLUTE ML JR, Rushmer TJ, Shi F, Fuller B, et al
    Renin-Angiotensin Inhibitors Decrease Recurrence After Turbt in Non-Muscle Invasive Bladder Cancer.
    J Urol. 2015 Jul 11. pii: S0022-5347(15)04360-8. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  880. ZARGAR-SHOSHTARI K, Zargar H, Lotan Y, Shah JB, et al
    A Multi-Institutional Analysis of Outcomes in Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy.
    J Urol. 2015 Jul 20. pii: S0022-5347(15)04421-3. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  881. CHANG SS
    Re: Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer.
    J Urol. 2015;194:334-5.
    Abstract     Related articles   

  882. SMITH ND, Prasad SM, Patel AR, Weiner AB, et al
    Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.
    J Urol. 2015 Jul 30. pii: S0022-5347(15)04499-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  883. YOKOMIZO A, Kanimoto Y, Okamura T, Ozono S, et al
    Randomized Controlled Study of the Efficacy, Safety and Quality of Life of Low-Dose Bacillus Calmette-Guerin Instillation Therapy for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2015 Aug 22. pii: S0022-5347(15)04674-1. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  884. PENSON DF
    Re: Association between Cannabis Use and the Risk of Bladder Cancer: Results from the California Men's Health Study.
    J Urol. 2015;194:667.
    Abstract     Related articles   

  885. CHANG SS
    Re: Contemporary Cost-Effectiveness Analysis Comparing Sequential bacillus Calmette-Guerin and Electromotive Mitomycin versus bacillus Calmette-Guerin Alone for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2015;194:666.
    Abstract     Related articles   

  886. CHANG SS
    Re: Intermediate-Term Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Urothelial Carcinoma.
    J Urol. 2015;194:44.
    Abstract     Related articles   

  887. GUPTA A, Long JB, Chen J, Gross CP, et al
    Risk of Vascular Toxicity with Platinum-based Chemotherapy in Elderly Patients with Bladder Cancer.
    J Urol. 2015 Sep 1. pii: S0022-5347(15)04708-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  888. VAN KESSEL KE, Van Neste L, Lurkin I, Zwarthoff EC, et al
    Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Hematuria Patients.
    J Urol. 2015 Aug 28. pii: S0022-5347(15)04705-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  889. SATHE A, Koshy N, Schmid SC, Thalgott M, et al
    CDK4/6-inhibition controls proliferation of bladder cancer and transcription of RB1.
    J Urol. 2015 Aug 26. pii: S0022-5347(15)04685-6. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  890. FAN EW, Li CC, Wu WJ, Huang CN, et al
    FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    J Urol. 2015;194:223-9.
    Abstract     Related articles   

  891. BROOKS M, Godoy G, Sun M, Shariat SF, et al
    External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival, and Overall Survival Following Radical Cystectomy.
    J Urol. 2015 Sep 4. pii: S0022-5347(15)04716-3. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  892. ATALA A
    Re: Loss of Expression of the Tumour Suppressor Gene AIMP3 Predicts Survival following Radiotherapy in Muscle-Invasive Bladder Cancer.
    J Urol. 2015;194:1162-3.
    Abstract     Related articles   

  893. CHANG SS
    Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer.
    J Urol. 2015;194:956.
    Abstract     Related articles   

  894. BANERJEE I, Yadav S, Priyadarshi S, Tomar V, et al
    Re: Clinical Outcomes of cT1 Micropapillary Bladder Cancer: D. L. Willis, M. I. Fernandez, R. J. Dickstein, S. Parikh, J. B. Shah, L. L. Pisters, C. C. Guo, S. Henderson, B. A. Czerniak, H. B. Grossman, C. P. Dinney and A. M. Kamat J Urol 2015;193:112
    J Urol. 2015 Sep 3. pii: S0022-5347(15)04139-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  895. DOWNS TM
    Reducing readmissions and mortality after radical cystectomy.
    J Urol. 2015;193:1461-2.
    Abstract     Related articles   

  896. ODISHO AY
    Editorial comment.
    J Urol. 2015;193:1613.
    Abstract     Related articles   

  897. Reply by author.
    J Urol. 2015;193:1613-4.
    Abstract     Related articles   

  898. WU TF, Li CF, Chien LH, Shen KH, et al
    Galectin-1 dysregulation independently predicts disease specific survival in bladder urothelial carcinoma.
    J Urol. 2015;193:1002-8.
    Abstract     Related articles   

    Editorial Comment.
    J Urol. 2015;194:439.
    Abstract     Related articles   

  900. FU LY, Adeniran AJ
    Adenocarcinoma Arising from a Bladder Diverticulum.
    J Urol. 2015;194:527-8.
    Abstract     Related articles   

  901. GIRI V, Jha AK, Tomar V, Banerjee I, et al
    Re: Novel Bladder Preservation Therapy with Osaka Medical College Regimen: H. Azuma, T. Inamoto, K. Takahara, H. Nomi, H. Hirano, N. Ibuki, H. Uehara, K. Komura, K. Minami, T. Uchimoto, K. Saito, T. Takai, N. Tanda, K. Yamamoto, Y. Narumi and S. Kiyam
    J Urol. 2015;194:263.
    Abstract     Related articles   

  902. WANG B, Wu S, Zeng H, Liu Z, et al
    CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    J Urol. 2015;194:556-62.
    Abstract     Related articles   

  903. DOWNS T
    Editorial comment.
    J Urol. 2015;193:450.
    Abstract     Related articles   

  904. DREICER R
    Interdisciplinary management of locally advanced and metastatic genitourinary cancers: a team sport.
    J Urol. 2015;193:389-90.
    Abstract     Related articles   

  905. LAU CS, Blackwell RH, Quek ML
    Radical cystectomy: open vs robotic approach.
    J Urol. 2015;193:400-2.
    Abstract     Related articles   

  906. GLEASON JM, Bowlin PR, Bagli DJ, Lorenzo AJ, et al
    A comprehensive review of pediatric urachal anomalies and predictive analysis for adult urachal adenocarcinoma.
    J Urol. 2015;193:632-6.
    Abstract     Related articles   

  907. YOUSSEF RF, von Rundstedt FC, Kapur P, Mosbah A, et al
    Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for squamous cell carcinoma.
    J Urol. 2015;193:451-6.
    Abstract     Related articles   

  908. AZUMA H, Inamoto T, Takahara K, Nomi H, et al
    Novel Bladder Preservation Therapy, OMC-Regimen: Combined Therapy using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis with Concurrent Radiation.
    J Urol. 2014 Aug 25. pii: S0022-5347(14)04349-3. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  909. SUN AJ, Djaladat H, Schuckman A, Miranda G, et al
    Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events.
    J Urol. 2015;193:565-9.
    Abstract     Related articles   

  910. HERR HW
    The Risk of Urinary Tract Infection after Flexible Cystoscopy in Bladder Tumor Patients who did not receive Prophylactic Antibiotics.
    J Urol. 2014 Jul 18. pii: S0022-5347(14)03963-9. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  911. LAMM DL
    Getting the Most Out of Bacillus Calmette-Guerin for Treatment of Bladder Cancer.
    J Urol. 2015 Oct 8. pii: S0022-5347(15)04960-5. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  912. SEFTEL AD
    Re: Evaluating Sexual Function in Women after Radical Cystectomy as Treatment for Bladder Cancer.
    J Urol. 2015;194:1232.
    Abstract     Related articles   

  913. PENSON DF
    Re: Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results from the Health Professionals Follow-up Study.
    J Urol. 2015;194:1231-2.
    Abstract     Related articles   

  914. CHANG SS
    Re: Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients.
    J Urol. 2015;194:1230.
    Abstract     Related articles   

  915. VAN OSCH FH, Jochems SH, van Schooten FJ, Bryan RT, et al
    Significant role for lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis.
    J Urol. 2015 Oct 30. pii: S0022-5347(15)05162-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  916. ZARGAR H, Zargar-Shoshtari K, Lotan Y, Shah JB, et al
    Final Pathologic Stage after Neoadjuvant Chemotherapy and Radical Cystectomy For Bladder Cancer: Does pT0 Predict Better Survival Than pTa/Tis/T1?
    J Urol. 2015 Oct 29. pii: S0022-5347(15)05153-8. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  917. LIN YC, Lin JF, Wen SI, Yang SC, et al
    Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells.
    J Urol. 2015 Oct 28. pii: S0022-5347(15)05148-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  918. JAMES AC, Izard JP, Holt SK, Calvert JK, et al
    Root-Causes and Modifiability of 30-day Hospital Readmissions Following Radical Cystectomy for Bladder Cancer Under 65 Years of Age.
    J Urol. 2015 Nov 7. pii: S0022-5347(15)05203-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  919. PARK JC, Gandhi NM, Carducci MA, Eisenberger MA, et al
    A Retrospective Analysis of the Effect of Time from Diagnosis to Cystectomy on Survival in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy.
    J Urol. 2015 Nov 17. pii: S0022-5347(15)05238-6. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  920. CHANG SS
    Re: Potential Impact of 18F-FDG PET/CT on Patients Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
    J Urol. 2015;194:955-6.
    Abstract     Related articles   

  921. CHANG SS
    Re: Metastases in Normal-Sized Pelvic Lymph Nodes: Detection with Diffusion-Weighted MR Imaging.
    J Urol. 2015;194:954-5.
    Abstract     Related articles   

  922. PARK SJ, Shim JW, Park HS, Eum DY, et al
    MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    Abstract     Related articles   

  923. HUANG Y, Zhang SD, McCrudden C, Chan KW, et al
    The prognostic significance of PD-L1 in bladder cancer.
    Oncol Rep. 2015;33:3075-84.
    Abstract     Related articles   

  924. SUN E, Fan X, Wang L, Lei M, et al
    Recombinant hIFN-alpha2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3985.
    Abstract     Related articles   

  925. PARK SL, Cho TM, Won SY, Song JH, et al
    MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4119.
    Abstract     Related articles   

  926. LOMBARD AP, Lim RM, Nakagawa RM, Vidallo KD, et al
    Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4117.
    Abstract     Related articles   

  927. TAKEUCHI H, Mmeje CO, Jinesh GG, Taoka R, et al
    Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4220.
    Abstract     Related articles   

  928. GAO D, Hu H, Wang Y, Yu W, et al
    CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
    Oncol Rep. 2015 Sep 24. doi: 10.3892/or.2015.4310.
    Abstract     Related articles   

  929. PAN XW, Li L, Huang Y, Huang H, et al
    Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.
    Oncol Rep. 2015 Oct 16. doi: 10.3892/or.2015.4335.
    Abstract     Related articles   

  930. YOON HY, Kim YJ, Kim JS, Kim YW, et al
    RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
    Oncol Rep. 2015 Nov 11. doi: 10.3892/or.2015.4409.
    Abstract     Related articles   

  931. WANG X, Chen E, Yang X, Wang Y, et al
    5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4492.
    Abstract     Related articles   

  932. BENADIBA S, Gauthier H, Ploussard G, Mongiat-Artus P, et al
    [Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy].
    Prog Urol. 2015 May 25. pii: S1166-7087(15)00129.
    Abstract     Related articles   

  933. PIGNOT G
    [Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer].
    Prog Urol. 2015 Jun 15. pii: S1166-7087(15)00177.
    Abstract     Related articles   

    [Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy].
    Prog Urol. 2015 Jun 9. pii: S1166-7087(15)00133.
    Abstract     Related articles   

  935. FIARD G, Pavillet J
    [The role of chemotherapy in bladder cancer].
    Prog Urol. 2015 Jul 21. pii: S1166-7087(15)00219.
    Abstract     Related articles   

  936. COQUARD R
    [Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554
    Prog Urol. 2015 Sep 23. pii: S1166-7087(15)00227.
    Abstract     Related articles   

  937. LAILLER G, Neuzillet Y, Rouanne M, Lebret T, et al
    [Assessment of the optimization of the conditions of mitomycin C intravesical instillation completion in the setting of non-muscle invasive bladder cancer treatment].
    Prog Urol. 2015 Nov 30. pii: S1166-7087(15)00688.
    Abstract     Related articles   

  938. HUPE MC, Merseburger AS, Gunter HH, Wustemann M, et al
    Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature.
    Urol Int. 2015.
    Abstract     Related articles   

  939. LATZ S, Umbach T, Goltz D, Kristiansen G, et al
    Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
    Urol Int. 2015.
    Abstract     Related articles   

  940. BRISUDA A, Pazourkova E, Soukup V, Horinek A, et al
    Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Urol Int. 2015.
    Abstract     Related articles   

  941. HORN T, Zahel T, Adt N, Schmid SC, et al
    Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
    Urol Int. 2015.
    Abstract     Related articles   

  942. AZIZ A, Madersbacher S, Otto W, Mayr R, et al
    Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
    Urol Int. 2015;94:37-44.
    Abstract     Related articles   

  943. COMPLOJ E, West J, Mian M, Kluth LA, et al
    Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
    Urol Int. 2015;94:25-30.
    Abstract     Related articles   

  944. HOFBAUER SL, Shariat SF, Chade DC, Sarkis AS, et al
    The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
    Urol Int. 2015.
    Abstract     Related articles   

  945. LIU B, Zhang C, Zhang Q, Liu G, et al
    Primary epithelioid hemangioendothelioma of the bladder: case report and review of the literature.
    Urol Int. 2015;94:240-3.
    Abstract     Related articles   

  946. LEI Y, Tong S, Zu X, Li Y, et al
    Extraperitoneal and transperitoneal laparoscopic partial cystectomy for benign non-urothelial bladder tumors: an initial experience.
    Urol Int. 2015;94:149-55.
    Abstract     Related articles   

  947. PALLESCHI G, Pastore AL, Carbone A
    Reply: To PMID 25817111.
    Urology. 2015;85:889.
    Abstract     Related articles   

  948. SCARPA RM, Cracco CM, Usai P
    Editorial comment.
    Urology. 2015;85:888-9.
    Abstract     Related articles   

  949. PALLESCHI G, Pastore AL, Ripoli A, Silvestri L, et al
    Videourodynamic evaluation of intracorporeally reconstructed orthotopic U-shaped ileal neobladders.
    Urology. 2015;85:883-9.
    Abstract     Related articles   

  950. PIETZAK EJ, Sterling ME, Smith ZL, Malkowicz SB, et al
    Outcomes of radical cystectomy in potential candidates for bladder preservation therapy.
    Urology. 2015;85:869-75.
    Abstract     Related articles   

  951. HENDERSON SJ, Kearns PJ, Tong CM, Reddy M, et al
    Patients with urinary bladder paragangliomas: a compiled case series from a literature review for clinical management.
    Urology. 2015;85:e25-9.
    Abstract     Related articles   

  952. MARIAPPAN P, Rai B, El-Mokadem I, Anderson CH, et al
    Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour (TURBT) vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Urology. 2015 Jul 2. pii: S0090-4295(15)00361.
    Abstract     Related articles   

  953. NGUYEN DP, Al Hussein Al Awamlh B, Faltas BM, O'Malley P, et al
    Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.
    Urology. 2015;86:99-107.
    Abstract     Related articles   

  954. WEGELIN O, Bartels DW, Tromp E, Kuypers KC, et al
    The effects of instrumentation on urine cytology and CK-20 analysis for the detection of bladder cancer.
    Urology. 2015 Jul 9. pii: S0090-4295(15)00633.
    Abstract     Related articles   

  955. PIETZAK EJ, Mucksavage P, Guzzo TJ, Malkowicz SB, et al
    Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Urology. 2015 Jul 16. pii: S0090-4295(15)00651.
    Abstract     Related articles   

  956. CARDONA-GRAU D, White MD
    Dr. Alan Yagoda and the Development of Systemic Therapy for Advanced Bladder Cancer.
    Urology. 2015 Jul 30. pii: S0090-4295(15)00644.
    Abstract     Related articles   

  957. AGUIAR L, Danialan R, Kim C
    A Case of High-grade Transitional Cell Carcinoma of the Bladder in a Pediatric Patient With Turner Syndrome.
    Urology. 2015;85:1477-9.
    Abstract     Related articles   

  958. COUFFIGNAL C, Desgrandchamps F, Mongiat-Artus P, Ravery V, et al
    The diagnostic and prognostic performance of urinary FGFR3 mutation analysis in bladder cancer surveillance: a prospective multicenter study.
    Urology. 2015 Sep 10. pii: S0090-4295(15)00802.
    Abstract     Related articles   

  959. NGUYEN DP, Al Hussein Al Awamlh B, Scherr DS
    Reply: To PMID 26142590.
    Urology. 2015;86:107.
    Abstract     Related articles   

  960. SIMONE G, Ferriero M, Gallucci M
    Editorial Comment.
    Urology. 2015;86:106-7.
    Abstract     Related articles   

  961. SOAVE A, John LM, Dahlem R, Minner S, et al
    The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Urology. 2015;86:92-8.
    Abstract     Related articles   

  962. SHAH SH, Movassaghi K, Skinner D, Dalag L, et al
    Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience.
    Urology. 2015;86:87-91.
    Abstract     Related articles   

  963. TURATI F, Bosetti C, Polesel J, Zucchetto A, et al
    Coffee, Tea, Cola and Bladder Cancer Risk: Dose- and Time-Relationships.
    Urology. 2015 Sep 25. pii: S0090-4295(15)00911.
    Abstract     Related articles   

  964. UMLAUF VN, Coerdt W, Leuschner I, Schroder A, et al
    How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?
    Urology. 2015;86:379-83.
    Abstract     Related articles   

  965. MOSCHINI M, Karnes RJ, Gandaglia G, Luzzago S, et al
    Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy during Radical Cystectomy: a Sensitivity Curve Analysis.
    Urology. 2015 Dec 9. pii: S0090-4295(15)01110.
    Abstract     Related articles   

  966. ZHOU B, Zhang P, Tang T, Liao H, et al
    Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
    BMC Cancer. 2015;15:433.
    Abstract     Related articles   

  967. HAYNE D, Stockler M, McCombie SP, Chalasani V, et al
    BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301).
    BMC Cancer. 2015;15:432.
    Abstract     Related articles   

  968. CASTELLANO D, Puente J, de Velasco G, Chirivella I, et al
    Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
    BMC Cancer. 2014;14:779.
    Abstract     Related articles   

  969. GREIFE A, Jankowiak S, Steinbring J, Nikpour P, et al
    Canonical Notch signalling is inactive in urothelial carcinoma.
    BMC Cancer. 2014;14:628.
    Abstract     Related articles   

  970. KU JH, Kang M, Kim HS, Jeong CW, et al
    Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.
    BMC Cancer. 2015;15:447.
    Abstract     Related articles   

  971. LEE JY, Cho KS, Kang DH, Jung HD, et al
    A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.
    BMC Cancer. 2015;15:566.
    Abstract     Related articles   

  972. ACAR O, Ozkurt E, Demir G, Sarac H, et al
    Determining the origin of synchronous multifocal bladder cancer by exome sequencing.
    BMC Cancer. 2015;15:871.
    Abstract     Related articles   

  973. SMOLENSKY D, Rathore K, Cekanova M
    Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    BMC Cancer. 2015;15:927.
    Abstract     Related articles   

  974. PINEDA S, Real FX, Kogevinas M, Carrato A, et al
    Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer.
    PLoS Genet. 2015;11:e1005689.
    Abstract     Related articles   

  975. LI X, Choi WW, Yan R, Yu H, et al
    The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    PLoS One. 2014;9:e105326.
    Abstract     Related articles   

  976. WANG YL, Jiang B, Yin FF, Shi HQ, et al
    Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0130122.
    Abstract     Related articles   

  977. ALEXANDER RE, Williamson SR, Richey J, Lopez-Beltran A, et al
    The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder.
    PLoS One. 2014;9:e95724.
    Abstract     Related articles   

  978. ANDERSSON E, Dahmcke CM, Steven K, Larsen LK, et al
    Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer.
    PLoS One. 2015;10:e0131889.
    Abstract     Related articles   

  979. BOSTROM MM, Irjala H, Mirtti T, Taimen P, et al
    Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.
    PLoS One. 2015;10:e0133552.
    Abstract     Related articles   

  980. YANG G, Xu Z, Lu W, Li X, et al
    Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method.
    PLoS One. 2015;10:e0134727.
    Abstract     Related articles   

  981. KIM YW, Yun SJ, Jeong P, Kim SK, et al
    The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.
    PLoS One. 2015;10:e0134552.
    Abstract     Related articles   

  982. YANG Y, Qu A, Liu J, Wang R, et al
    Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.
    PLoS One. 2015;10:e0135168.
    Abstract     Related articles   

  983. PAN CX, Zhang H, Tepper CG, Lin TY, et al
    Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
    PLoS One. 2015;10:e0134346.
    Abstract     Related articles   

  984. BRITO RB, Malta CS, Souza DM, Matheus LH, et al
    1-Methyl-D-Tryptophan Potentiates TGF-beta-Induced Epithelial-Mesenchymal Transition in T24 Human Bladder Cancer Cells.
    PLoS One. 2015;10:e0134858.
    Abstract     Related articles   

  985. SCHWENDER H, Selinski S, Blaszkewicz M, Marchan R, et al
    Correction: Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers.
    PLoS One. 2015;10:e0137937.
    Abstract     Related articles   

  986. KITCHEN MO, Bryan RT, Haworth KE, Emes RD, et al
    Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    PLoS One. 2015;10:e0137003.
    Abstract     Related articles   

  987. FUKUHARA H, Kureishi M, Khoda T, Inoue K, et al
    The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer.
    PLoS One. 2015;10:e0136416.
    Abstract     Related articles   

  988. DHAWAN D, Paoloni M, Shukradas S, Choudhury DR, et al
    Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.
    PLoS One. 2015;10:e0136688.
    Abstract     Related articles   

  989. COSTA C, Pereira S, Lima L, Peixoto A, et al
    Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    PLoS One. 2015;10:e0141253.
    Abstract     Related articles   

  990. CHEN MC, Chen YL, Lee CF, Hung CH, et al
    Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.
    PLoS One. 2015;10:e0143594.
    Abstract     Related articles   

  991. ZHANG X, Zhang Y, Liu X, Fang A, et al
    MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
    PLoS One. 2015;10:e0143441.
    Abstract     Related articles   

  992. CHAWKI S, Ploussard G, Montlahuc C, Verine J, et al
    Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review.
    PLoS One. 2015;10:e0144237.
    Abstract     Related articles   

  993. SUN L, Lu J, Niu Z, Ding K, et al
    A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.
    PLoS One. 2015;10:e0144484.
    Abstract     Related articles   

  994. HONG S, Kim SC, Kwon T, Jeong IG, et al
    Is bladder tumor location associated with prostate cancer detection after intravesical bacillus calmette-guerin instillation?
    PLoS One. 2014;9:e103791.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.